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MSD Mean square displacement  
Nagg Number of aggregation  
NHS N-hydroxysuccinimide  
NMR Nuclear magnetic resonance  
NTI Napthalimide 
NTI-NHS 2,5-dioxopyrrolidin-1-yl 6-(6-morpholino-1,3-dioxo-1H-
benzo[de]isoquinolin-2(3H)-yl)hexanoate 
PA Peptide amphiphiles 
pAA Poly (acrylic acid) 
PABTC (Propanoic acid)yl butyl trithiocarbonate  
PBS Phosphate-buffered saline 
PC-3 Epithelial prostate cancer cells 
pDMAEMA Poly (2-dimethylamino) ethyl methacrylate 
PEG Poly (ethylene glycol)  
pEtOx Poly(2-ethyl-2-oxazoline) 
PFS Polyferrocenylsilane 
pMMA Poly (methyl methacrylate)  
PMS N-methyl dibenzopyrazine methyl sulfate  
PTFE Polytetrafluoroethylene 
PYR Pyrene 
PYR-NHS 1-Pyrenebutyric acid N-hydroxysuccinimide ester 
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RAFT Reversible addition − fragmentation chain-transfer polymerization 
SANS Small angle neutron scattering 
SEC Size exclusion chromatography 
SLD Scattering length density 
SLS Static Light Scattering  
SPPS Solid phase peptide synthesis 
STORM Stochastic optical reconstruction microscopy  
TEM Transmission electron microscopy  
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TIPS Triisopropylsilane  
UPy Ureido-pyrimidinone 
UV Ultraviolet 
XTT 2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide 
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Chapter 1 Introduction 
 
1.1 Supramolecular polymers 
Supramolecular interactions can be found throughout nature and are essential to most 
biological functions. The fundamental concept of molecules interacting with one 
another, covalently or non-covalently, is used to explain what is happening on a 
chemical level. For a long time, the assumption was that the properties of a molecule 
were governed primarily by the properties of the single molecule. With our growing 
understanding of chemistry it became harder to ignore the effect environment played 
on a system; therefore giving rise to the new idea that molecular interactions could not 
be ignored. Key concepts, such as coordination chemistry, the lock-and-key model 
and host-guest binding all elude to this notion of molecular interactions. The prefix 
‘supra’ means ‘beyond the limits’ of or ‘outside of’ and from this the term 
‘supramolecular’ has been used to denote the interactions outside the limits of the 
molecule. The distinction between ‘intra’ and ‘inter’ molecular is made by 
differentiating how the atoms are bonded together, either covalently or non-covalently.  
Supramolecular polymers consist of molecules that spontaneously self-assemble with 
one another via non-covalent interactions. These structures can form a range of 
different morphologies on the nanoscale, such as nanofibers,1 nanoribbons2 and 
nanotubes.3 Examples of these systems can also be found in nature, such as actin and 
tubulin.4 Making synthetic supramolecular polymers via a ‘bottom up’ approach is a 
very appealing proposition for chemists.5 Using well-established organic chemistry 
we can manipulate the functionality of these unimers to systemically promote 
assembly, introduce secondary interactions and provide attachment sites for post-
modification. This gives us endless possibility to design and tailor these materials for 
a wide range of applications.  
1.1.1 Non-covalent interactions in supramolecular polymers 
In classical polymerisation monomers are covalently linked together to form a long 
polymer chain; in supramolecular polymerisation a long chain of unimers is linked by 
non-covalent interactions. The range of non-covalent bonds between molecules 
include hydrogen bonding, hydrophobic interactions, π-π stacking and van der Waals. 
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Due to non-covalent bonds being much weaker than covalent bonds they are usually 
reversible with temperature and concentration. 
Importantly, in supramolecular polymers the bonding arrangements are most 
commonly both, multivalent and directional. Multivalency is crucial for the continued 
growth of the polymer passed two units. Additionally, the bond strength scales with 
the number of bonds between two monomers. Due to the directionality of the bond 
being maintained over a long range, the assembled aggregates typically adopt an 
elongated morphology such as a nanotube or nanofiber.  
1.1.2 Mechanism of growth 
Depending on the unimer the self-assembly of the supramolecular polymerisation 
should proceed via one of two prominent mechanisms; isodesmic or cooperative.6, 7 
See Scheme 1.1. 
In an isodesmic polymerization the reactivity of the unimer and the growing chain are 
equal; as a result the polymerisation occurs in a way comparable to step-growth 
polymerization. This happens when there are no neighbouring group effects. The 
decrease in free energy with each successive monomer attachment to the growing 
polymer remains constant throughout the polymerisation. The aggregation number is 
dependent on temperature and concentration, increasing the temperature or decreasing 
the concentration will lead to disassembly and vice versa. Most notably, there is no 
critical concentration and temperature. 
When proceeding by a cooperative mechanism the polymerisation occurs in a non-
linear fashion, in two stages, a nucleation stage followed by an elongation stage. For 
the formation of a nucleus a critical concentration/temperature must be reached 
(nucleation stage). After this point, further increases in concentration or decreases in 
temperature leads to the growth of the polymer chain from the nucleus (elongation 
stage). Notably, the change in rate of polymerisation between the nucleation and 
elongation stages can be represented by two different rate constants. In a cooperative 
mechanism the rate constant for nucleation is smaller than of the elongation. This 
chain-growth polymerisation, whereby the monomers can only react to the ‘active’ 
growing chain, makes it possible to control the dispersity of the polymer via living 
polymerisation techniques.  
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Scheme 1.1. The self-assembly process in an isodesmic and cooperative mechanism. 
 
1.1.3 Living supramolecular polymers 
Nature produces mono-disperse polymers, such as proteins, to carry out vital living 
processes. However, achieving this for synthetic polymers has been far more 
challenging. Dispersity is the measure of the heterogeneity of polymers, the larger the 
length distribution of chains the higher the dispersity. Conventional polymers, where 
the monomers are linked covalently, have used living polymerisation techniques to 
better control the length and distribution of polymers. This principle has also been 
adopted to control the dispersity of supramolecular polymers. During polymerisation, 
an initiator can react with another monomer to generate a new active centre on the 
monomer. With each successive monomer addition the polymer propagates and the 
last monomer to react importantly retain the active group. In a living system, where 
the initiation is faster than propagation and there are no side reactions via termination 
Chapter 1 
4 
 
or chain transfer, all the active chain end can be nucleated before growing uniformly 
– this results in a much lower dispersity polymer. Controlling the dispersity of the 
polymers is vital as the degree of polymerisation (DP) i.e. the polymer chain length, 
can drastically effect the properties of the material. Lower dispersity polymers will 
enables us to better target, tune and reproduce the polymers for their desired 
applications. Using the concept of ‘living’ supramolecular polymerization we can 
synthesise uniform self-assembled structures.  
The first approach leading to a living supramolecular polymerization established and 
developed by Manners, Winnik and co-workers utilises crystallisation-driven self-
assembly (CDSA). In CDSA, a block co-polymer is self-assembled as one block is 
solvophobic and the other is solvophillic. Importantly the solvophobic block, most 
commonly polyferrocenylsilane (PFS), forms a semi-crystalline core. This 
crystallinity generates directionality and kinetically traps the self-assembled structures 
preventing them from dynamically disassembling and re-assembling. Upon sonication 
these self-assembled structures can be broken up into uniform ‘seed micelles’. In the 
presence of additional unimers the seed micelles behave as nuclei from which they 
can propagate to produce uniform elongated supramolecular polymers. More recently, 
work has been focused on using this method to create aqueous monodispersed micelles 
and 2D-platelet morphologies using polylactides are the core-forming block. 8-10 
 
Scheme 1.2. Simplified route to uniform cylindrical micelles via crystallization driven 
self-assembly. a) block co-polymer unimer with a crystallisable PFS core (orange) and 
phosphine containing polysiloxane corona  (purple). Adapted from Lunn et al.11 
Aida and co-workers also developed a method to forming living supramolecular 
polymers using a metastable cage-like structures. The initiator and monomer species 
consist of a concave structure of aromatic rings functionalised with a range of different 
R-groups on the periphery. Once assembled, the phenyl groups take part in π-π 
stacking, but crucially, the R-groups contain amide bonds which can hydrogen bond 
to each other. The carboxylic acid group on the initiator can be used to spring open 
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the metastable cage monomer; this hydrogen bond reorganisation initiates the 
polymerisation and the resultant initiator-monomer complex can further propagate 
with more monomers during the chain growth stage. The subsequent polymers were 
shown to be well controlled via size exclusion chromatography (SEC) and atomic 
force microscopy (AFM). In addition, both SEC and AFM also showed size or length 
of the polymers could be tuned by increasing the monomer to initiator ratio, as 
expected in a living polymerisation.   
 
Figure 1.1 Living supramolecular polymerisation of metastable cage-like species. a) 
General mechanism of step-growth and chain-growth polymerisation. b) Chemical 
structure of the metastable cage-like monomer, c) Schematic representation of the 
open ‘initiator’, caged ‘monomer’ species and d) growing polymer. Reproduced from 
Kang et al. 12 
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Subsequently, a third way to produce defined supramolecular polymers was developed 
by Sugiyasu, Takeushi and co-workers, using the formation of stabilised aggregates 
of zinc or copper complexed porphyrin derivatives. As the zinc porphyrin-based 
molecules were heated they preferential disassembled to their unimeric state. Upon 
cooling they stacked to form J-aggregated nanoparticles however given a few days to 
equilibrate the system could rearrange to form H-aggregated nanofibers. This 
phenomenon can be seen to take place much faster (in a few hours) if the H-aggregates 
are put in the presence of the some J-aggregates. This suggests the transformation into 
H-aggregates can be initiated by ‘seeding’. By introducing ‘nuclei’ or ‘seeds’ the 
polymerization can proceed via a controlled pathway, resulting in the formation of 
uniform fibres, see Figure 1.1 a and b.13 More recently these porphyrins have also been 
shown to form uniform assemblies via CDSA approach, see Figure 1.1c.   
 
Figure 1.2 a) Chemical structures of a zinc-porphyrin complex (unimer). Schematic 
representation of living supramolecular assembly of porphyrin derivatives via b) 
heating (adapted from Ogi et al)13 and c) seeded growth (Reproduced from Jung et 
al)14. 
All these approaches illustrate remarkable control over the supramolecular 
polymerisation, however require highly specialised unimers and conditions. Despite 
these advances, designing controlled self-assembly systems for biological relevant 
systems in aqueous conditions has been much more challenging. 
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1.2 Self-assembling peptide  
Hydrogen bonds can be found everywhere in the natural world. For this reason, when 
designing supramolecular polymers for biological applications, many systems use 
hydrogen bonds to recreate their desired nanostructures. In particular, the self-
assembling peptides, which have the ability to spontaneously aggregate to form long 
ordered structures have been widely exploited to form β-sheets and α-helixes 
assemblies. 
By using amino acids which are naturally occurring in the body, the aim is to minimise 
their potential biological side effects. These systems have garnered much attention for 
their potential biological applications in drug delivery15, 16 and tissue engineering.17 
Additionally, the amino acid building blocks of peptides provide an extensive library 
of functional groups with their own in-built self-assembly motif in the form of amide 
bonds. The amide bonds on the peptides can take part in hydrogen bonding to form 
directional β-sheet arrays.  
1.2.1 ß-Sheet (hydrogen bond) self-assembly 
The amide bonds perpendicular to the peptide backbone can take part in hydrogen 
bonding to form supramolecular structures. Due to hydrogen bonds being directional, 
peptides have a tendency to form one-dimensional elongated structures, typically 
nanofibers. The β-sheet formation of the peptide can occur in a parallel or anti-parallel 
fashion, scheme 1.3.  
 
Scheme 1.3. Parallel and Anti-parallel β–sheet formation. 
The simplest example of self-assembling peptides are the dipeptide systems.18, 19 The 
general design of these dipeptides consist of two amino acids, typically aromatic, 
attached to an hydrophobic R group on the N-terminus via a linker (i.e. –O-CH2- or –
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CH2-), see Scheme 1.4a. The interplay of hydrophobicity and hydrophilicity between 
these exchangeable groups make this system very versatile. The design of the 
dipeptides are optimised to self-assemble in water and as a result they form extremely 
long nanofibers, which in turn entangle to produce gel networks. Using their simple 
design and ability to form hydrogels in water, these peptides have been studied for 
their applications as 3D cell culture supports17 and energy transfer systems for use in 
bioelectronics20. 
Another key example of supramolecular peptide polymers are peptide amphiphiles 
(PA). PAs contain an alkyl hydrophobic tail, β-sheet forming middle segment and 
outer charged groups for stabilisation, see Scheme 1.4.21 The hydrophobic tail and 
hydrophilic charged surface groups allow them to behave as surfactants in aqueous 
media. However, unlikely typical surfactants which self-assemble into spheres to form 
micelles, the directional hydrogen bonding β-sheet motif forces the peptides into a 
nanofibillar conformation. This two-fold self-assembly system has been used to 
develop bio-mimetic self-assembled nanofibers to aid bone mineralisation and 
targeted cell-signalling.15, 22  
 
Scheme 1.4. Examples and general design features of self-assembling a) dipeptides 
and b) peptide amphiphiles. 
 
Non-peptide self-assembly systems which use amide bonds such as the bis-urea,23 
benzene 1,3,5, tricarboxamides (BTA)24, 25 and ureido-pyrimidinone (UPy)26-28 motifs 
have also been shown to self-assemble into β-sheet stacking elongated nanostructures. 
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1.3 Self-assembling cyclic peptides 
1.3.1 History and Design 
Naturally occurring cyclic peptides have been found to possess remarkable toxicity 
and antimicrobial activity.29 For this reason, cyclic peptides have been synthetically 
reproduced in the lab in order to study their potential as antibiotics or therapeutic 
drugs. To give an example, Cyclosporin A has become a pharmaceutical success as an 
immunosuppressive drug. 56e 
In 1974, De Santis et al. first proposed that cyclic peptides with a specific 
conformation could stack on top of each other to form nanotubes.30 He hypothesised 
that a linear peptide with an even number of α alternating D- and L- amino acids could 
from a flat ring like structure upon cyclisation. With this configuration the amide 
bonds on the cyclic peptide would be perpendicular to the ring enabling them hydrogen 
bond with each other, see Figure 1.3a. In 1993, with increasing methods to make and 
characterise synthetic peptides, Ghadiri and co-workers were able to observe these 
self-assembling cyclic peptide nanotubes by transmission electron microscopy (TEM) 
(Figure 1.3b).3 
 
Figure 1.3 a) The chemical structure and b) transmission electron microscopy (TEM) 
of self-assembling cyclic peptide nanotubes. Reproduced from Ghadiri et al.3 
These cyclic peptide nanotubes (CPNT) have a number of desirable design features. 
Using a ‘bottom up’ approach the sequence of the amino acids in the peptide can be 
altered to provide solubility and site specific functionality. The functional R group of 
the amino acid protrude out of the nanotube assembly – therefore decorating the 
periphery of the peptide, see Figure 1.3a. The functional groups on the CPNT are 
chosen carefully to promote assembly and provide handles for post-modification. Due 
to the self-assembly process, the peptide can readily precipitate in most solvents, other 
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than trifluoroacetic acid (TFA), dimethyl sulfoxide (DMSO) and dimethylformamide 
(DMF), significantly improving the yields during the purification steps.3, 31, 32  
The amino acid composition of self-assembling cyclic peptides has been reviewed in 
detailed by Ghadiri, Granja and co-workers.3, 31-35 The study established that the octa-
peptide structure provided plenty of nodes for functionality whilst still mainly the 
planar ring-structure for self-assembly. The internal diameter and distance between 
two cyclic octa-peptides was found to be about 7.5 Å and 4.5 Å respectively - 
determined by X-ray crystallography, electron diffraction and mathematical 
modelling. Further advances have been made in orthogonal conjugation chemistry, 
including in this thesis, to provide a library of different CPNT conjugates.  
1.3.2 Self-assembling cyclic peptide-polymer conjugates 
A major advantage of self-assembling cyclic peptides has been the ease in post-
modification using the in-built functionality of the peptide. Most significantly, the 
attachment of polymers to the outside of the peptide ring has dramatically improved 
the solubility of these nanostructures. Biesalski and coworkers were first to report the 
attachment of polymers to cyclic peptide nanotubes using pNIPAM synthesised via 
atom transfer radical polymerisation (ATRP).36 The introduction of the polymer not 
only changes the solubility of the unimer but also effects the self-assembly of the 
nanotube. The sterically bulky polymers on the side of the peptide also prevented 
lateral aggregation of the peptide and therefore lead to the formation of single 
nanotubes. The same group went on to study this steric behaviour on the self-assembly 
and showed by increase the size of the polymer chain they observed a decrease in the 
overall size of aggregates.  
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Scheme 1.5. Cyclic peptides laterally aggregate to form long nanotubular bundles. 
Upon polymer conjugation the polymer arms help solubilise the CPNT and prevent 
lateral aggregation. 
Our group has gone on to attach a wide range of polymers such as polyethylene glycol 
(PEG), poly(2-ethyl-2-oxazoline) (pEtOx)37, 38 and polymers synthesised via 
reversible addition − fragmentation chain-transfer polymerization (RAFT) to the 
CPNT.39 The attachment of hydrophilic polymers to the periphery of CPNT has 
allowed them to be studied for a host of bio-therapeutic applications, see section 1.3.3.  
Much of the focus has been on attaching highly functional polymers with low 
dispersities to the cyclic peptide to study their potential bio-therapeutic applications. 
For this reason many of the conjugates were designed to be stable in aqueous systems. 
Early examples of these systems looked at the responsive behaviour of CP-polymers 
in water to stimuli such as temperature and pH. Chapman et al. showed that the 
conjugates could be thermo-responsive. Above the cloud point temperature, the cyclic 
peptides decorated with poly (2-ethyl-2-oxazoline) (pEtOx) were shown to form large 
micrometre particles.37  
The supramolecular nature of the peptide assembly has also been exploited to form 
pH responsive self-assemblies. Previously poly (acrylic acid) (pAA) conjugated 
nanotubes were reported to be shorter at high pH upon deprotonation of the carboxylic 
acid group.40 This behaviour was explored further by Catrouillet et al. to show using 
poly (2-dimethylamino) ethyl methacrylate (pDMAEMA) the nanotubular length 
could be tuned at different pHs.41 By tuning the pH and therefore the amount of charge 
on the polymer arms, the self-assembly could be disrupted to different degrees. 
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1.3.3 Applications  
Before the attachment of polymers, these cyclic peptides were shown to have 
interesting antimicrobial activity. In 2001, Fernandez-Lopez and co-workers showed 
that these peptides were selectively membrane active against bacterial strains, 
including Escherichia coli and Staphylococcus aureus.32 The studies showed the 
‘carpet-like’ self-assembly of the peptide in the membrane lead to fast cell death and 
avoided receptor interactions, which in turn helps prevent anti-bacterial resistance.  
 
Scheme 1.6. Different modes of action a) intramolecular pore, b) barrel stave and c) 
carpet-like of self-assembling cyclic peptide nanotubes in lipid bilayer membranes. 
Reproduced from Fernandez-Lopez et al.32 
Wang et al. reported the use of PEGylated CPNT bundles to deliver the model 
anticancer drug doxorubicin (DOX).42 The DOX was mixed with cyclic peptide 
decorated with PEG, cysteine and glutamic acid residues. They hypothesised the 
charge residues could form ion-pairs which could lead to the nanotubular bundling. 
Increase activity of the drug was observed with the carrier and the carrier showed no 
toxicity with the absence of the drug. 
Following on, Blunden et al. showed the delivery of the ruthenium-based anticancer 
drug RAPTA-C.43 A hydrophilic co-polymer of hydroxyl ethyl acrylate (HEA) and 2-
chloroethyl methacrylate (CEMA) was synthesised to not only solubilise the CPNT in 
aqueous conditions but also provide the attachment point for the drug. 
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Figure 1.4. RAPTA-C functionalised cyclic peptide polymers. Reproduced from 
Blunden et al. 43 
More recently, Larnaudie et al. used a more potent Iridium-based anticancer drug, see 
Figure 1.5. The IC50 of the drug-conjugated polymer-CPNT was lower than that of 
the free polymer or drug.16, 44 The CPNT conjugates produced better specificity with 
a six-fold decrease in toxicity on the ovarian cancer cell line (A2780). Interestingly, 
this did not correlate with a higher content of the Iridium in the cells, which implies 
the drug carrier provides a more efficient mode of action in comparison to its controls.  
In a biological setting, many of these dynamic systems are injected or delivered at low 
concentrations, where they are likely disassemble. If the assemblies are highly 
dynamic, this could explains why many of these systems are very short in length, 
typically around 10 nm, at the biologically relevant concentrations. Stabilising the 
self-assembled nanostructures would enable us to better control the benefits we 
receive from the supramolecular nature of these systems. 
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Figure 1.5. a. Structure of cyclic peptides conjugated with poly (N-(2-
Hydroxypropyl) methacrylamide (pHPMA) and anti-cancer iridium complex. b. IC50 
of the free drug, polymer and conjugate. c. The mass of iridium found in the 
membrane, cytosol, cytoskeleton and nucleus of the cells. Reproduced from Larnaudie 
et al. 44 
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In recent years, the study of amphiphilic cyclic peptide-polymers have given rise to a 
secondary self-assembly of individual nanotubes into tubisomes.45 This secondary 
assembly is facilitated by attaching a hydrophilic polymer to one side of the cyclic 
peptide and a hydrophobic polymer to the other. The cyclic peptides not only hydrogen 
bond to form peptide nanotubes, the hydrophobic polymer chains additional aggregate 
with one another to hold a secondary tubular structure, see Figure 1.6. In aqueous 
conditions, this two-fold self-assembly can be observed using small angle neutron 
scattering (SANS). The secondary structure afforded by the tubisome system provides 
a much larger pore cavity (diameter 16 nm) in comparison to the single nanotubes 
(diameter 0.7 nm). This larger cavity was shown to perforate the lysosomal membrane 
to release calcein into the cytosol.45   
 
 
Figure 1.6 a) Tubisomes formed via a two-fold self-assembly of amphiphilic cyclic 
peptide nanotubes using β–sheet hydrogen bonding and hydrophobic interactions. 
Calcein release study to observe lysosomal escape. b-d) Artistic representation of the 
dye leaking into the cytosol through the tubisomes. e) Calcein escape from the 
lysosome in HEK293 cells, f) pre-treated with pBA27-b-pPEGA45 (polymer) or g) 
pBA27-CP-pPEGA45 (CP conjugate). Scale bar set to 200µm. Reproduced from 
Brendel et al.45 
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1.4 Characterisation of self-assembled nanostructures 
1.4.1 Fluorescence probes 
Many living systems are governed by molecular interactions which take part on the 
nanoscale. Fluorescent molecules (i.e. fluorophores) can be especially useful in 
biology to investigate molecular interactions in situ in complex biological 
environments, such as inside cells. 
For a compound to fluoresce it needs to emit light upon excitation. This emission of 
light occurs when the compound relaxes back to the ground state and in the process 
emits a photon. The energy of the photon released is equal to hv where h = Plank’s 
constant and v= frequency of light.  
Förster resonance energy transfer (FRET) is a fluorescence phenomenon that is often 
utilised in biology to observe the interaction of two different molecules. If the two 
different species are labelled with FRET dyes, one with a donor and the other with an 
acceptor, it is possible for the electronic excited state of the donor to transfer energy 
via non-radiative dipole-dipole coupling. This energy transfer can be monitor by the 
measuring the fluorescence emission of the acceptor upon excitation of the donor. For 
this energy transfer to take place two conditions must be met. First, the emission of 
the donor and the excitation of the acceptor must overlap. Second, the donor and 
acceptor must be close enough in proximity for the dipole-dipole coupling to take 
place, typically within 10-100 nm.  
For this thesis, FRET has been extensively used to monitor the dynamic exchange of 
cyclic peptides between nanotubes in solution. If the donor and acceptor dye labelled 
cyclic peptide-polymer unimers are self-assembled in the same nanotube, after 
dynamically exchanging, this proximity dependent energy transfer should be 
observed. 
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1.4.2 Light scattering 
Light scattering is a powerful method to characterise nanoscale self-assemblies in 
solution. In particular, techniques such as static light scattering (SLS) and small angle 
neutron scattering (SANS) are frequently used to measure the size of self-assembled 
structures which are not spherical, like nanotubes.  
These methods rely on measuring the scattering intensity at various different angles in 
relation to the incident beam. Using the equation: 
𝑞 =
4𝜋
𝜆0
𝑠𝑖𝑛
𝜃
2
 (𝑆𝐴𝑁𝑆)    𝑜𝑟   𝑞 =
4𝜋𝑛
𝜆0
𝑠𝑖𝑛
𝜃
2
 (𝑆𝐿𝑆)                         (1) 
where q = wave vector, 𝜆0= wavelength of the incident beam, n = refractive index of 
the solvent and 𝜃 is the angle of the detector from the incident beam, a range of q 
values can be obtained by varying the angle.  
 
Figure 1.7 Illustrating the scattering angle of the detector in relation to the incident 
beam. 
The wave vector q is also inversely proportional to the window of observation. 
Therefore the smaller your wave vector q, the larger your window of observation for 
a fixed wavelength of light, 𝜆0.  
In SANS, using the fact that the scattering length density between deuterium and 
hydrogen is significantly different, the contrast between deuterated solvents and the 
hydrogen containing molecules, is used to measure a scattering profile of the 
aggregates in solution. The scattering profile can be measured and fitted to a range of 
different models to obtain information about the size and shape of the assemblies. 
In SLS, the aggregates are prepared in a range of different concentrations and measure 
at various different angles.  
𝑅𝜃 =
𝐼𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛(𝜃)−𝐼𝑠𝑜𝑙𝑣𝑒𝑛𝑡(𝜃)
𝐼𝑡𝑜𝑙𝑢𝑒𝑛𝑒(𝜃)
 ∙ (
𝑛𝑠𝑜𝑙𝑣𝑒𝑛𝑡
𝑛𝑡𝑜𝑙𝑢𝑒𝑛𝑒
)
2
∙ 𝑅𝑡𝑜𝑙𝑢𝑒𝑛𝑒               (2) 
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I = scattering intensity, n= refractive index, R = Rayleigh ratio.  
This equation calculates the Rayleigh ratio at a given angle of the solution after taking 
into account the solvent and toluene reference. 
𝐾 =
4𝜋2𝑛𝑠𝑜𝑙𝑣𝑒𝑛𝑡
2
𝜆4𝑁𝑎
∙ (
𝑑𝑛
𝑑𝑐
)
2
            (3) 
K = optical constant, Na= Avogadro constant, dn/dc = the change in refractive index 
over the change in concentration.  
𝐾𝐶
𝑅𝜃
=  
1
𝑀𝑎
∙ (1 +
𝑞2∙𝑅𝑔
2
3
)         (4) 
Rg = radius of gyration. 
The average molecular weight of the aggregate Ma can be obtained by plotting the 
KC/RѲ versus q
2 in a linear regression in accordance with equation (4). At infinite 
dilution, where there are no inter-particle interactions average molecular weight of the 
aggregates should be constant. If the molecular weight of the aggregate Ma is the same 
over infinite dilutions, the average number of aggregation can be calculated from the 
following equation (6): 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑔𝑔𝑟𝑒𝑎𝑡𝑖𝑜𝑛 =  
𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑎𝑔𝑔𝑟𝑒𝑎𝑡𝑒
𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑢𝑛𝑖𝑚𝑒𝑟
       (5) 
 
These scattering techniques have been utilised throughout this thesis to characterise 
the aggregates in solution. 
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1.5 Scope and motivation of this thesis 
Self-assembling cyclic peptide nanotubes have gained considerable interest due to 
their promising biological applications in drug delivery and as anti-microbials. This 
can be attributed to their wide range of design features including their ease of 
functionalisation and reversible supramolecular assembly. The host of functionalities 
on the peptide can also be used as handles for post-modification. A major step towards 
using these systems in vitro and in vivo has been the conjugation of water-soluble 
polymers to the cyclic peptides which have shown to significantly improve the 
solubility CPNTs in water.  
Our group has looked at using the non-covalent supramolecular nature of the cyclic 
peptides for drug delivery systems. In an ideal case, a supramolecular drug carrier 
should show an enhanced therapeutic response compared to its unimeric counterpart 
but once delivered, be able to depolymerise to its non-assembled state - making it 
easier to be cleared from the body. This could help prevent accumulation in organs, 
which can lead to future complications.  
It remains unclear whether these self-assembled nanotubes are kinetically stable or are 
constantly exchanging between nanotubes in a thermodynamic equilibrium. As this 
behaviour is of paramount importance to predict their performance in future biological 
studies, an in-depth study of the dynamic nature of supramolecular drug conjugates is 
critical.  
For our supramolecular system, we designed CP–polymer conjugates modified with 
fluorescent dyes and used Förster resonance energy transfer (FRET) to probe the 
dynamic nature of the resulting nanotubes. Fluorescence is a powerful tool to study 
close intramolecular interactions and investigate the dynamic behaviour of 
supramolecular systems. In the context of cyclic peptides, Granja and co-workers 
previously employed FRET to study the hydrogen-bonding interaction of small 
dimeric cyclic peptides.46 Here, we propose to use FRET to gain an insight into the 
stacking of cyclic peptide nanotubes (CPNTs) in situ and provide vital information 
about the dynamics of these one-dimensional supramolecular structures. In addition, 
the use of FRET allowed us to observe the behaviour of these nanotubes in mammalian 
cells in vitro, thus providing essential information about their dynamics in a complex 
biological environment.  
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With our growing mechanistic understanding of supramolecular chemistry from 
model self-assembling systems, the next important step will be to tailor their behaviour 
to their intended applications. In a biological setting, many of these dynamic systems 
will be injected or delivered at low concentrations, where they are likely to 
disassemble.  
Inspired by the hierarchical design and structure of proteins, a two-fold self-assembly 
approach was developed to help stabilise the elongated peptide nanostructure. The 
hydrogen bond stacking of the cyclic peptides provides the primary structure and 
overall cylindrical morphology of the self-assembled aggregates. Here we introduce a 
secondary structural driving force in the form of a hydrophobic region around the 
peptide to stabilise the single cyclic peptide nanotubes. The individual nanotubes 
remain independent due to the hydrophilic corona stabilising the nanostructures in 
water. This hierarchical approach offers a method to stabilise, not only cyclic peptide 
assemblies, but also other β-sheet forming self-assembled architectures.  
This thesis aims to highlight the importance of understanding the supramolecular 
behaviour and how armed with this information we can better design these promising 
synthetic supramolecular polymers.  
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Chapter 2 Design and synthesis of cyclic 
peptide-polymer-dye conjugates to probe 
their dynamics. 
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2.4 Introduction 
Recently, attention has been focused on designing supramolecular systems that are 
increasingly relevant for biomedical applications.1-3 Self-assembling cyclic peptide 
nanotubes in particular have garnered interest in this field, as they can be easily 
modified for range of therapeutics. A key advantage of these systems is their built in 
functionality, the R-group of the amino acids can either contain functionality itself, 
such as a charge, but equally be used as a conjugation site for post-modification. Our 
group have previously used both convergent and divergent methods to create cyclic 
peptide-polymer conjugations.4 
As for these and other similar supramolecular structures, it remains unclear whether 
the self-assembled aggregates remain kinetically stable or dynamic in biological 
environments. Understanding the self-assembly behaviour is of paramount importance 
to explain and predict their performance in vitro and in vivo studies; and why an in-
depth study into the dynamic nature of CP-polymer conjugates is imperative.  
Herein, we designed CP-polymer conjugates modified with fluorescent dyes and used 
Förster resonance energy transfer (FRET) to probe the dynamic nature of the resulting 
nanotubes. Fluorescence is a powerful tool to study close intramolecular interactions 
and investigate the dynamic behaviour of supramolecular systems. 5,6 In the context of 
cyclic peptides, Granja et al. previously employed FRET to study the hydrogen-
bonding interaction of small dimeric cyclic peptides.7 Herein, we propose to use FRET 
to gain an insight into the stacking of cyclic peptide nanotubes (CPNTs) in situ and 
provide vital information about the dynamics of these one-dimensional 
supramolecular structures. To gain a detailed understanding, key parameters such as 
solvent and concentration were varied, and their influence on the assembly process 
was studied.  
We know the conjugation of water-soluble polymers was vital to improve their 
solubility, therefore new water-soluble FRET dye conjugates were built to study the 
effect of environment on supramolecular dynamics. In this chapter, using a ‘bottom 
up’ approach, the design, synthesis and characterisation of asymmetric model 
conjugates, which contain both a dye and polymer, were established.  
  
Chapter 2 
26 
 
2.5 Results and Discussion 
2.5.1 Synthesis of asymmetric orthogonal cyclic peptide 
In order to investigate the dynamics of self-assembled cyclic peptide–polymer 
nanotubes, a new class of dye-conjugated peptides was synthesized. To infer 
information about the kinetic exchange of these systems, each cyclic peptide required 
the conjugation of a single FRET dye to its periphery. Using a “bottom up” approach, 
a sequence of amino acids was designed to yield an asymmetric cyclic peptide, which 
could be used to conjugate both a dye and polymer in an orthogonal manner.8 The 
bespoke asymmetric cyclic peptide 3 was used in this study, contained both an azide 
and amine moiety on its periphery. 
 
Figure 2.1 Chemical structures of asymmetric cyclic peptide for orthogonal 
conjugation. 
The linear octa-peptide was synthesised using solid phase peptide synthesis from the 
2-chlorotrityl resin. With the exception of the azide containing amino acid synthesised 
in our group according to the literature,8 all other amino acids were purchased from 
Iris Biotech GmbH. The linear octa-peptide (1) was grown in a stepwise fashion via 
solid phase peptide synthesis (SPPS), see Scheme 2.1. The Fmoc procted amino acids 
were sequentially deprotected and reacted to the growing peptide chain on the resin. 
1- [Bis (dimethyl amino) methylene] -1H -1,2,3 - triazolo [4,5-b] pyridinium 3-oxid 
hexa fluoro phosphate (HATU) and  2- (1H - benzotriazol-1-yl) - 1,1,3,3 – tetra methyl 
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uranium  hexa fluoro phosphate (HBTU) was used to activate the peptide coupling. 
Detailed synthetic procedure can be found in the experimental.  
 
Scheme 2.1 Simplified scheme to make alternating D- and L- linear octa-peptide using 
solid phase peptide synthesis (SPPS).  
This resin releases the peptide in the presence of a mild acid selectively without 
disturbing the Boc groups on the peptide. The linear peptide (1) was collected, purified 
and analysed via proton nuclear magnetic resonance (1H NMR), high performance 
liquid chromatography (HPLC) and electrospray ionisation time-of-flight (ESI-ToF) 
mass spectrometry – see experimental and appendix for spectra. Proton NMR of the 
compound was assigned fully, notably the spectra showed the target compound with 
some residual hexafluoroisopropanol (HFIP) and DMF. ESI-ToF mass spectroscopy 
qualitatively confirmed the formation of the linear peptide exclusively, see (Figure 
2.2).  
The coupling agent 4- (4,6- dimethoxy - 1,3,5 - triazin-2-yl) – 4 – methyl 
morpholinium tetra fluoroborate (DMTMM . BF4) was used for the cyclisation, see 
Scheme 2.2. During the activation of the C-terminus on the peptide, the base 4-
methylmorpholine (NMM) was produced causing the reaction to auto-accelerate 
without the need of additional base. This reduces the concentration of base in the 
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system which can scramble the stereochemistry of terminal amino acids. For this 
reason, DMTMM . BF4 was used to reduce the chance of epimerization and maximise 
the formation of the desired flat ring-like cyclic peptide.9 The cyclisation was also 
performed at high dilution to avoid intermolecular coupling and promote 
intramolecular cyclisation. The orthogonal Boc protection groups enable the coupling 
to only take place at the ends of the peptide. In order to purify the peptide, precipitation 
in ice-cold methanol was used to remove impurities. As racemised or truncated linear 
peptide will not form the planar cyclic structure needed for self-assembly, these 
peptides remain in solution whilst the CPs with the correct conformation form 
aggregates and precipitate. NMR and ESI-ToF analysis show the Boc protected cyclic 
peptide (2) – see appendix and Figure 2.2, respectively.  
 
Scheme 2.2 Cyclisation of linear octa-peptide (1) to form protected cyclic peptide (2). 
Boc deprotection of the cyclic peptide using TFA, TIPS and H2O to give the 
asymmetric azide amine cyclic peptide (3). 
A mixture of trifluoroacetic acid (TFA), triisopropylsilane (TIPS) and H2O (18:1:1 vol 
ratio) was used to deprotect the Boc groups from the cyclic peptide, see Scheme 2.2. 
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The reaction was followed by ESI-ToF mass spectrometry. After 3 hours the peak 
associated with the protected cyclic peptide disappeared. The reaction mixture was 
precipitated in diethyl ether to give a pure product characterised by ESI-ToF mass 
spectra and 1H NMR – see Figure 2.2 and Appendix, respectively. As purification was 
completed via precipitation, no preparative HPLC was needed for this step.  
 
Figure 2.2 Electron Spray Ionisation – Time of Flight (ESI-ToF) mass spectra of the 
linear peptide (1), protected cyclic peptide (2) and deprotected cyclic peptide (3). 
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2.5.2 Synthesis of the cyclic peptide-pyrene/napthalimide conjugates 
The first FRET pair attached on the cyclic peptide was the pyrene (PYR) donor and 
napthalimide (NTI) acceptor. These dyes are relatively inexpensive compared to other 
commercially available FRET pairs, making them more suitable for the development 
and optimisation of these systems. The coupling of the dye to the cyclic peptide 
required an efficient chemistry to yield only the conjugate and excess dye, importantly 
leaving no unmodified cyclic peptide which would be difficult to purify. For this 
reason, our group has utilised amide bond forming coupling chemistry, which not only 
efficiently functionalises the CP but result in a stable bond which is not disturbed once 
formed. One method to activating the carboxylic acid group to reaction with the amide 
moiety on the CP, is by functionalising it with a good leaving group such as N-
hydroxysuccinimide (NHS). The coupling agent 1-ethyl-3- (3-dimethylaminopropyl) 
carbodiimide (EDC) was used to attach the NHS group onto the carboxylic acid on the 
dye (Figure 2.3).  
 
Figure 2.3 Synthetic route to NHS-functionalised napthalimide (NTI) dye. 
 
Using the amine group on the asymmetric cyclic peptide, we can selectively attach the 
dye to a specific site on the molecule. Independently, the NHS-functionalised pyrene 
or napthalimide was reacted with the peptide to yield the cyclic peptide-pyrene (CP-
PYR) or cyclic peptide-napthalimide (CP-NTI) conjugates respectively.   
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Scheme 2.3 Schematic representation of the synthetic route to the cyclic peptide-dyes. 
Due to the strong hydrogen bonds between the CPs, which cause the formation of the 
nanotubular assemblies, strong hydrogen bond competitive solvents were needed to 
break up these aggregates to perform the conjugation reactions.10 Therefore, either 
DMSO or DMF were used to ensure the cyclic peptides remained in solution during 
the coupling reaction. A base was also introduced to ensure the amine group of the 
lysine was deprotonated and able to couple with the dye. 
After verifying the product qualitatively via ESI-ToF mass spectrometry, the 
purification was attempted using a number of different precipitation solvents such as 
ice-cold acetone, methanol and THF. Purification of this reaction proved to be 
extremely difficult because of the similarity in solubility of dye and CP-dye conjugate 
in most solvents. Under these conditions both the dye and CP-dyes remained in 
solution and no precipitate was formed. Finally, ice-cold toluene was used to 
precipitate the CP-dyes whilst the dye remained in supernatant.  
HPLC analysis of these compounds were attempted, however, the CP-dye conjugates 
were insoluble in the solvents needed to run the samples, such as acetonitrile and 
methanol, due to their hydrophobicity. The signals obtained were therefore weak and 
inconclusive. ESI mass spectrometry and proton NMR of the CP-PYR (4) and CP-
NTI (5) conjugates were therefore used to confirm the product, this can be found in 
Figure 2.4 and experimental. 
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Figure 2.4 ESI-ToF Mass spectra of the deprotected cyclic peptide (3), the pyrene 
conjugated cyclic peptide (4) and the napthalimide conjugated cyclic peptide (5). 
 
2.5.3 Synthesis of the cyclic peptide-pyrene/napthalimide-polymer conjugates 
To provide solubility in water these conjugates were modified with a poly (ethylene 
glycol) (PEG) polymer. PEGylation not only improved the solubility of the CPs in a 
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range of solvents, but also prevents the nanotubes from laterally aggregating and 
precipitating.  The orthogonality of the peptide enables us to attach the polymer on the 
peptide using the azide group. Importantly, to study the mixing of these conjugates in 
solution each peptide must contain a dye and polymer.  
Dye
Dye
Dye
Dye
 
Scheme 2.4 a) Pre-functionalisation and b) Post-functionalisation methods to 
attaching the polymer to the CP-dye conjugates. 
The pre-functionalisation method required first modifying the polymer with a strained 
alkyne. This was done using an NHS-amine coupling reaction (Scheme 2.5a). As a 
result, the PEG was modified with a strained alkyne, ready to react with the azide on 
the peptide. Due to the highly insoluble cyclic peptide-dye compounds, size exclusion 
chromatography in DMF was used to observe the disappearance of the cyclic peptide 
upon conjugation. DMF is a good solvent for cyclic peptides as the solvent can 
compete with the hydrogen bonding sites of the cyclic peptide, therefore disrupting 
the self-assembly between the CPs. After 3 days mixing the azide functionalised cyclic 
peptide-napthalimide (CP-NTI, 5) and strained alkyne modified PEG (20kDa), two 
distributions could be observed in the SEC trace, see Figure 2.5. The first lower 
molecular weight distribution is similar to the cyclic peptide or cyclic peptide-dye, the 
second larger molecular weight distribution is close that of the free polymer. This 
suggests that there was still a lot of unreacted cyclic peptide-dye in the reaction 
mixture. 
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Figure 2.5 SEC chromatograph in DMF with 0.1% LiBr comparing the cyclic peptide 
(CP), polymer (PEG-NH2 20kDa), cyclic peptide-napthalimide (CP-NTI) conjugate 
and the reaction mixture of CP-NTI and PEG using the first approach (pre-
functionalisation).  
Next, the post-functionalisation method was attempted, see Scheme 2.5b. Using the 
same chemistry in the reverse order, the azide functionalised CP-dye is reacted with a 
strained alkyne-NHS group (BCN-NHS) first. This formed a NHS functionalised 
cyclic peptide-dye conjugate which could be reacted with the amine functionalised 
PEG polymer. After the conjugation, no lower molecular weight distribution 
associated with the cyclic peptide-dye was observed. This suggested the all the CP-
dye was reacted with polymer. 
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Figure 2.6 SEC chromatograph comparing the cyclic peptide (CP), polymer (PEG-
NH2 20kDa), cyclic peptide-dye conjugate and the reaction mixture of CP-NTI and 
PEG using the second approach (post-functionalisation). 
The attachment of the hydrophilic polymer lead to a substantial improvement in the 
solubility of the CP conjugates. As the cyclic peptides assemble in H2O a significant 
amount of the polymer conjugates could be recovered while removing any free 
polymer or residual small molecules via dialysis. Also, the improved hydrophilicity of 
the conjugates meant it was possible run them in a reverse-phase HPLC. The UV 
detector on the HPLC was set to the 280 nm which corresponds to the tryptophan on 
the cyclic peptide. The fluorescence detector was set to the relative excitation and 
emission maxima of the dye (pyrene or napthalimide). Strong fluorescence and UV 
signals were detected from the compounds with one clear major compound and some 
minor impurity, see Figure 2.7.  
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Figure 2.7 Normalised HPLC of PEG-cyclic peptide-dyes (PEG-CP-NTI). UV 
detector set to 280nm (tryptophan in the CP) and the fluorescence set to emission of 
the dyes.  
 
2.5.4 Dynamics of the cyclic peptide-pyrene/napthalimide-polymer conjugates 
Pyrene has two distinctive qualities; firstly it has an exceptionally long excited state 
lifetime and, secondly, it can form excimers with itself.11 The formation of this 
excimer can be observed when two pyrene molecules are stacked on top of each other. 
This arrangement enables the energy transfer between the excited pyrene and a 
ground-state pyrene to take place leading to a characteristic emission band around 
475 nm. Excimer formation has been utilised to observe the dynamic behaviour of 
phospholipids in membrane bilayers.5 Pyrene can also behave as a donor for Förster 
resonance energy transfer (FRET) with napthalimide as an acceptor. This use of 
fluorescence energy transfer has been widely adopted to look at intermolecular 
interactions on the molecular or cellular levels. FRET utilises its proximity dependent 
mechanism to investigate the distance from two molecules.12 For this energy transfer 
to take place two prerequisites must be met. Firstly, the emission band of the donor 
must overlap with the excitation of the acceptor molecule. Second, for an efficient 
energy transfer the donor and acceptor molecules must be within 1-10 nm of each 
Chapter 2 
37 
 
other. Granja et al. previously synthesised N-methylated dimeric cyclic peptides with 
pyrene (electron donor) and dapoxyl (electron acceptor) FRET pairs.7 Nevertheless, 
for cyclic peptides, which form self-assembling nanotubes, these dynamics have not 
been studied so far. Especially, in the case of cyclic peptide-polymer conjugates, this 
knowledge is crucial to fully understand their self-assembly behaviour. 
In this FRET system, pyrene was used as the donor and napthalimide (NTI) was used 
as the acceptor. Figure 2.8b clearly shows the emission band of the pyrene conjugate 
and excitation band of the napthalimide conjugate overlaps, fulfilling our first 
requirement for FRET to take place. Next, using the second requirement which is the 
proximity, we can relate the FRET behaviour to the conjugates being close to each 
other, i.e. in the same nanotube (Figure 2.8a). The distance between two cyclic 
peptides is4.5 Å, so if the dyes are with a few units of an assembled nanotube FRET 
should be observed. 
 
Figure 2.8 Normalised absorption and fluorescence spectra of the pyrene and 
napthalimide conjugate (PEG-CP-PYR, 6 and PEG-CP-NTI, 7). The emission spectra 
of the donor (PEG-CP-PYR) overlaps with the excitation of the acceptor (PEG-CP-
NTI).  
Pyrene and napthalimide are inexpensive dyes compared to other commercial FRET 
dyes; this was the main reason for why they were used during the optimisation of the 
synthesis. However it is worth noting they have some limitations as a FRET pair. The 
excimer band (~ 475 nm) overlaps with the emission spectra of the napthalimide (~ 
525 nm) this makes it difficult to observe the emission of the acceptor directly. Also, 
there is some direct excitation of the acceptor at the absorption maxima of donor (λ 
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max ~ 350 nm) which can artificially increase the FRET emission, therefore leading to 
some acceptor emission not due to the energy transfer. In an ideal FRET system, upon 
excitation of the donor the resulting emission of the donor can excite the acceptor and 
therefore an emission of the acceptor is observed. The extent of FRET is often 
quantified as the following ratio,  
𝐹𝑅𝐸𝑇 𝑟𝑎𝑡𝑖𝑜 =  
𝑒𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑜𝑓 𝑎𝑐𝑐𝑒𝑝𝑡𝑜𝑟∗
𝑒𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑜𝑓 𝑎𝑐𝑐𝑒𝑝𝑡𝑜𝑟 ∗ +𝑒𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑜𝑓 𝑑𝑜𝑛𝑜𝑟∗
           (1) 
* upon excitation of donor. 
For this reason, once the synthetic procedure of these dyes were optimised, the 
conjugates were remade using the Cyanine 3 and 5 (Cy3 and Cy5). This well-studied 
commercial FRET pair was able to circumvent the key spectral issues surrounding the 
pyrene and napthalimide dyes. 
2.5.5 Synthesis of Cyclic Peptide-Cyanine Dye-Polymer Conjugates 
In order to investigate the dynamic kinetics of self-assembled cyclic peptide–polymer 
nanotubes, a new library of dye-conjugated peptides was synthesized. To infer 
information about the kinetic exchange of these systems, Cyanine 3 and 5 dyes were 
conjugated to peptide as a FRET donor and acceptor pair.  
 
Scheme 2.5 Schematic representation of the synthesis of cyclic peptide-dye-polymer 
conjugates. 
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Using the attachment chemistry previously developed, the FRET dyes were 
conjugated onto the cyclic peptide via N-hydroxysuccinimide (NHS)–amine coupling. 
The efficiency of this step was assessed using high pressure liquid chromatography 
(HPLC) and was shown to be quantitative, enabling the FRET emission to directly 
inform us of the exchange kinetics of the supramolecular system. Cyanine FRET dyes 
Cy3 and Cy5 were also chosen as the FRET pair as their high extinction coefficients 
enable the detection of FRET at very low concentrations. Additionally, the spectral 
overlap of these dyes is ideal to avoid undesirable excitation of the acceptor. Unlike 
the pyrene and napthalimide dyes which were used previously, there is little to no 
direct excitation of the acceptor at the absorption maxima of the donor. Moreover, the 
absence of the excimer band makes it easier to quantify the emission from the acceptor. 
The Cyanine dyes and their equivalent conjugates were significantly less hydrophobic 
than those with pyrene and napthalimide, therefore, could be dissolved in a range of 
different polar solvents. This made it possible to characterize the dye-functionalization 
of the conjugates via electrospray ionization time-of-flight (ESI-ToF) mass 
spectrometry (Figures 2.10) and HPLC equipped with ultraviolet (UV) and 
fluorescence detection (Figures 2.9). This method to characterise these compounds 
qualitatively (ESI-ToF) and quantitatively (HPLC) was particularly valuable, as these 
techniques do not require large sacrificially amounts of these expensive compounds.  
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Figure 2.9 High performance liquid chromatographs (HPLC) of the a) donor 
conjugates and b) acceptor conjugates. Cyanine 3 and 5 were also measured to 
compare the polarity of the conjugates to the free dyes.  
 
Figure 2.10 Electron spray – Time of Flight (ESI-ToF) mass spectra of the a) 
asymmetric cyclic peptide, cyclic peptide-Cy3 conjugate (CP-Cy3) and NHS-
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functionalised cyclic peptide-Cy3 conjugate (NHS-CP-Cy3). b) ESI-ToF spectra of 
the equivalent Cy5 conjugates. 
A non-fluorescent conjugate was also synthesized as a control. For this conjugate to 
best mimic the self-assembly of the dye-functionalized conjugates, the free amine of 
the lysine residue was converted to an amide group, by conjugation with valeric acid 
using the peptide coupling agent 1-[Bis(dimethylamino) methylene] -1H-1,2,3-
triazolo [4,5-b] pyridinium 3-oxid hexa fluoro phosphate (HATU) (Scheme 3.1). The 
alkyl chain on the valeric acid replicates the alkyl linker on the NHS-functionalized 
dyes. Once again, ESI-ToF was used to qualitatively confirm the cyclic peptide with 
the alkyl chain, Figure 2.11.  
 
Figure 2.11  Electron spray ionisation – Time of Flight (ESI-ToF) mass spectrometry 
of the asymmetric cyclic peptide and cyclic peptide with the control alkyl chain 
without the dye (CP-Alkyl). The NHS-functionalised CP-Alkyl conjugate was not 
soluble to perform ESI-ToF.  
Using the same synthetic protocol developed previously, the post-functionalisation 
method was used to conjugate the water-soluble polymer to the cyclic peptide to 
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control the length of the tubular assembly and prevent lateral aggregation. The ESI-
ToF was used to confirm the NHS-functionalisation of the CP conjugates, see Figure 
2.10.  
This time, the NHS-functionalisation could be quantified using HPLC due to the 
solubility and clear shift in hydrophilicity between the CP-dye and NHS-CP-dye 
compounds (Figure 2.9). Upon conjugation of the PEG polymer to the cyclic peptide 
a large shift to lower retention time in the reverse-phase HPLC was observed. This 
shows the conjugation of the hydrophilic polymer significantly increased the 
hydrophilicity of the cyclic peptide containing conjugate.  
The change in polarity in the HPLC was also used to confirm the conjugation and 
purity of the control CP-polymer conjugate. Due to the absence of a fluorescent dye 
to follow in the HPLC, for the PEG-CP-alkyl conjugate, multiple UV absorption 
detectors were used to follow the polymer at 220 nm and the tryptophan on the cyclic 
peptide at 280 nm. As expected the cyclic peptide can be seen in both the 220 nm and 
280 nm wavelength detector; the PEG polymer only shows very weak absorption at 
220 and no signal at 280 nm. Upon PEG conjugation a clear shift between the 
unfunctionalised cyclic peptide, free polymer and conjugate (PEG-CP-Alkyl) can be 
observed. Notably, the PEG-CP-Alkyl compound shows strong absorption at the same 
retention time in both 220 nm and 280 nm UV-HPLC spectra.  
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Figure 2.12 High performance liquid chromatographs (HPLC) of the asymmetric 
cyclic peptide, poly (ethylene glycol) (PEG 20kDa) polymer and the control conjugate 
with the absence of a FRET dye. 
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2.6 Conclusion 
In this chapter, a new class of self-assembling cyclic peptides were developed to study 
their dynamic behaviour. Using FRET dyes on the periphery, which are proximity-
dependent, the mixing of dye conjugates could be used to directly inform us of the 
exchanging CPs between the supramolecular assemblies. The focus on developing 
these systems for biological applications has given rise to a variety of water-soluble 
nanotubular structures, by attaching hydrophilic polymers to the peptide. As both the 
dye and polymer are essential to the monitoring and composition, a ‘bottom up’ 
approach was used to synthesise an asymmetric self-assembling peptide, with two 
different conjugation sites. The orthogonality of the azide and amine on the cyclic 
peptide enabled us to selectively attach both a dye and polymer to the periphery.  
The dyes used here were carefully selected for the spectral properties as FRET pairs. 
Using the conjugates developed here, the next chapter will delve into the effect of 
environment can have on the exchange of unimers in a supramolecular system. More 
importantly, the design and synthesis of these orthogonal conjugates are not limited to 
cyclic peptide; this method can be used to measure the dynamics of a host of 
supramolecular polymers.  
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2.7 Experimental 
2.7.1 Material 
Fmoc-protected amino acids and coupling agents were purchased from Iris Biotech 
GmbH. Napthalimide carboxylic acid was gifted from Dr Benjamin M Long in the 
Jolliffe group at the University of Sydney. The amine functionalized PEG was 
purchased from Rapp Polymere. All other chemicals stated were purchased from 
Sigma-Aldrich, (Gillingham, UK) unless otherwise stated. Solvents were purchased 
from several departmental suppliers— Honeywell, Fisher and Sigma-Aldrich. 
2.7.2 Characterisation 
2.7.2.1 Nuclear magnetic resonance spectroscopy (NMR)  
1H NMR spectrum were measured using a Bruker DPX-300 or DPX-400 NMR 
spectrometer which operated at 300.13 and 400.05 MHz respectively. The residual 
solvent peaks were used as internal references. Deuterated trifluoroacetic acid (d-
TFA) (δH = 11.5 ppm) was used to measure the peptides.  
2.7.2.2 Size-exclusion chromatography (SEC) / Gel permeation chromatography 
(GPC)  
The size-exclusion chromatograms (GPC) were measured using an Agilent PL50 
instrument with a differential refractive index (DRI) detector. The instrument 
contained two PolarGel D columns (linear MW operating range: 200 to 400,000 g/mol 
(PS equivalent)) and a PolarGel 5μm guard column. DMF with 0.1% LiBr additive 
was used as the eluent. The system ran at 1 mg/min (50ºC), with an injection volume 
of 100 μL. The samples were prepared by filtering them through 0.22 μm pore size 
membranes, before injection. Agilent EasyVial poly (methyl methacrylate) standards 
were used to calibrate the instrument and output data was analysed using Agilent 
GPC/SEC software.  
2.7.2.3 Vibrational spectroscopy - Infrared Spectra  
Attenuated total refection (ATR) Fourier transform infrared (FTIR) spectra was 
measured using a Bruker Vector 22 FT-IR spectrometer.  
2.7.2.4 Ultraviolet/visible (UV-vis) absorption spectroscopy  
UV-vis absorption spectra was measured using an Agilent Technologies Cary 60 UV-
Vis spectrometer. The total concentration of the samples were kept to 35 µM. 
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2.7.2.5 Fluorescence emission spectroscopy  
Fluorescence emission spectra was measured using an Agilent Technologies Cary 
Eclipse Fluorescence spectrometer. The total concentration of the samples were kept 
to 35 µM. 
Mixing study (PEG-CP-PYR and PEG-CP-NTI): First, 35 µM stock solutions of PEG-
CP-PYR and PEG-CP-NTI were prepared in the water. The emission spectra of the 
PEG-CP-PYR was measured before the addition of the PEG-CP-NTI conjugate. Upon 
mixing, the fluorescence emission spectra was taken using the Agilent Kinetic 
software. The excitation of the donor was set to 345 nm. 
2.7.2.6 High performance liquid chromatography (HPLC)  
High performance liquid chromatograms (HPLC) was measured using an Agilent 
Technologies 1200 Series, equipped with a Luna 5u C18 100 Å, 250 x 4.6 mm column. 
Solvent mixtures of Methanol/Water and Acetonitrile/Water were used. All solvents 
contained 0.05 vol% TFA.  
Method 
Time/ mins Water + 0.05% TFA Acetonitrile + 0.05% TFA 
0 5 95 
5 5 95 
25 95 5 
30-35 95 5 
35 5 95 
 
2.7.2.7 Mass spectrometry (ESI-TOF)  
Electronspray ionisation (ESI) – time of flight (TOF) mass spectra (MS) was measured 
using a Bruker MicroTOF to characterise the peptides (linear and cyclic). Samples 
were dissolved in methanol. The instrument can achieve less than 5 ppm mass 
accuracy.  
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2.7.3 Peptide Synthesis  
2.7.3.1 Solid phase peptide synthesis – linear peptide 
A linear octapeptide was sequenced via solid phase peptide synthesis (SPPS).  
 
 
Scheme 2.6 Simplified scheme to make alternating D- and L- linear octa-peptide using 
solid phase peptide synthesis (SPPS). 
This method has been adapted from similar procedures to synthesis other cyclic 
peptides with different amino acid sequences.2  
In order to obtain an accurate amino acid sequence Fmoc protected amino acids were 
used. 2-chlorotrityl chloride resin (0.7 g, 0.77 mmol, 1.0 eq) was weighed into a 
sintered syringe. The resin was swollen for more than 30 minutes in DCM with 
constant agitation. The amino acid solution was prepared using Fmoc-D-Leu-OH 
(0.554g, 1.54 mmol, 2 eq), DIPEA (0.796 g, 6.16 mmol, 8 eq) in DCM (3 mL). The 
solution was bubbled with N2 for 15 minutes. The DCM used to swell the solution was 
drained and then the amino acid solution was added to the resin, this suspension was 
shaken for 2 hours. The loaded resin was then washed with a solution of 
MeOH/DIPEA/DCM (2:1:17, 3 x 8 mL) followed by DCM (3 x 8 mL), DMF (3 x 8 
mL) and DCM (3 x 8 mL) washes. A negligible sample of the resin was then 
transferred to a vial, dried under vacuum and then weighed. The loading of the resin 
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was calculated by deprotecting the sample of the resin, this was done by agitating the 
sample in a piperidine/DMF (1:4 vol, 1mL) solution for 20 minutes.  
The deprotected sample was then diluted in DMF by a factor of 100 in order to obtain 
the exact absorption value via a UV-Vis spectrometer. The absorption value was used 
to calculate the concentration of loaded resin using the Fmoc peak at λ = 301 nm with 
ε = 7800 M-1 cm-1. The remaining resin in the sintered syringe and swollen using DCM 
(8 mL) for 30 minutes. After draining the DCM, the resin was washed with DMF (3 x 
8mL). The Fmoc groups were cleaved using a piperidine/DMF solution 2 x (1:4 vol, 
8mL, 5 minutes) and agitation. After Fmoc deprotection the resin was washed with 
DMF (5 x (8 mL, 30 seconds)), DCM (5 x (8 mL, 30 seconds)) and DMF (5 x (8 mL, 
30 seconds)). Next the second amino acid was coupled. A solution containing the 
Fmoc-L-Lys (N3)-OH (synthesised in the group by Tobias Klein) (0.568 g, 1.15 mmol, 
1.5 eq), HATU (0.437 g, 1.15 mmol, 1.5eq), DIPEA (0.299 g, 2.31 mmol, 3 eq) and 
DMF (3 mL) was bubbled under N2 gas for 10 minutes. The solution was then drawn 
into the syringe containing the resin. The solution and resin mixture was agitated 
overnight. The solution was then drained and the resin was washed in DMF (5 x (8 
mL, 30 seconds)), DCM (3 x (8 mL, 30 seconds)) and DMF (3 x (8 mL, 30 seconds)) 
after which the deprotection and washing steps were repeated. Subsequent amino acids 
were coupled using Fmoc-amino acid (2.31 mmol, 3eq), HBTU (0.905g, 2.39 mmol, 
3.1 eq) and DIPEA (0.597 g, 4.62 mmol, 6 eq). Addition and deprotection steps were 
repeated for each amino acid until the sequence was completed. After the final amino 
acid was added, deprotected and washed the linear peptide was cleaved from resin 
using a cleaving solution composed of HFIP/DCM (1:4 vol, 3 x (8 mL, 10 minutes)). 
To obtain the linear peptide remaining in the syringe further DCM (3 x (8mL, 30 
seconds)) washes were completed. The filtrates containing the linear peptide were 
concentrated in vacuo to obtain an off-white powder.  
Linear peptide (1) 
Yield: 71% 
1H NMR: (500MHz, TFA-d) δ ppm, 8.11-8.14 (m, 2H, Trp aromatic), 7.28-7.57 (m, 
8H, Trp aromatic), 5.17 (m, 2H, Trp-α-H), 4.55-4.69 (m, 5H, Leu-α-H + Lys-α-H), 
4.25 (t, J = 8Hz, 1H, Lys-α-NH-H), 3.13-3.49 (m, 8H, Trp CH2 + Lys CH2), 2.67 (m, 
2H, Lys(N3) CH2), 1.13-2.06 (m, 53H, Leu aliphatic CH CH2, Lys(N3) aliphatic CH2, 
Boc CH3, 0.76-0.95 (m, 28H, Leu aliphatic CH3, Lys(N3) aliphatic CH2) 
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MS (ESI-ToF): [M+H]+ calculated 1524.9 and found 1525.0, [M+Na]+  calculated 
1546.9 and found 1546.9. 
 
2.7.4 Cyclisation 
 
Scheme 2.7 Cyclisation of linear octa-peptide (1) to form protected cyclic peptide (2). 
 
The linear peptide (1) (1.442 g, 0.946 mmol, 1.0 eq) was dissolved in DMF (100 mL) 
using sonication till the solution was clear. The solution was bubbled with N2 (g) at 
room temperature then put into an ice bath until cooled. DMTMM . BF4 (0.466 g, 1.420 
mmol 1.5 eq) in DMF (10 mL) was purged with N2 (g) then added to the cooled linear 
peptide solution dropwise. The solution was stirred constantly for 91 hours under N2 
(g) at room temperature. DMF was removed in vacuo. Purification of the cyclic 
peptide was done using ice-cold methanol 3 x (20 mL) via centrifugation in 50 mL 
centrifuge tubes (7000 rpm, 5 mins). The cyclic peptide which formed a solid 
precipitate, at the bottom of the centrifuge tubes, was collected, transferred and dried 
under vacuum.  
 
 
Cyclic peptide Boc protected (2) 
Yield: 41%, 0.592g 
1H NMR: (500MHz, TFA-d) δ ppm, 8.09-8.11 (d, 2H, Trp aromatic), 8.09-8.11 (d, 
2H, Trp aromatic), 7.61-7.62 (d, 2H, Trp aromatic), 7.51 (s, 2H, Trp aromatic), 7.29-
7.37 (dt, 4H, Trp aromatic), 5.19 (t, 2H, Trp-α-H), 4.76 (m, 2H, Lys-α-H), 4.68-4.71 
(m, 4H, Leu-α-H), 3.37-3.49 (m, 4H, Trp CH2 + Lys CH2), 3.07-3.26 (m, 4H, Lys CH2, 
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Lys(N3) CH2), 2.70 (t, 2H, Lys(N3) CH2), 1.04-1.82 (m, 53H, Leu aliphatic CH CH2, 
Lys(N3) aliphatic CH2, Boc CH3, 0.75-0.84 (m, 28H, Leu aliphatic CH3, Lys(N3) 
aliphatic CH2) 
MS (ESI-ToF): [M+Na]+  calculated 1528.9 and found 1528.9. 
 
2.7.5 Deprotection of the cyclic peptide 
 
Scheme 2.8 Boc deprotection of cyclic peptide. 
Boc groups were removed in using a deprotection solution of TFA/TIPS/H2O (18:1:1 
vol, 5 mL). The protected cyclic peptide (2) was agitated for 3 hours in the 
deprotection solution, then triturated using ice-cold diethyl ether and washed twice 
more with ice-cold diethyl ether. The off-white powder was collected and dried under 
vacuum. 
 
Cyclic peptide Boc deprotected (3) 
Yield: 93%, 0.2084 g 
1H NMR: (500MHz, TFA-d) δ ppm, 6.70-7.56 (m, 10H, Trp aromatic), 5.11 (t, 2H, 
Trp-α-H), 4.76 (m, 6H, Leu-α-H, Lys-α-H), 3.07-3.49 (m, 4H, Trp CH2 + Lys CH2), 
3.07-3.26 (m, 4H, Lys CH2, Lys(N3) CH2), 2.70 (t, 2H, Lys(N3) CH2), 1.04-1.82 (m, 
26H, Leu aliphatic CH CH2, Lys(N3) aliphatic CH2, 0.74-0.79 (m, 28H, Leu aliphatic 
CH3, Lys(N3) aliphatic CH2) 
MS (ESI-ToF): [M+Na]+  calculated 1206.8 and found 1206.8. 
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2.7.6 N-hydroxysuccinimide (NHS) functionalisation of the napthalimide (NTI) 
dye 
 
 
Figure 2.13 Synthetic route to NHS-functionalised napthalimide (NTI) dye. 
 
The napthalimide dye, 6 - (6-morpholino - 1,3-dioxo - 1H - benzo [de] isoquinolin -2 
(3H) - yl) hexanoic acid (0.2066 g, 0.521 mmol, 1.0 eq), NHS (0.072g, 0.626 mmol, 
1.2 eq) and DMAP (6.4 mg, 0.052 mmol, 0.1 eq) were dissolved in DCM (35 mL) and 
left stirring in an ice bath until cooled. In a separate vial, 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrogen chloride (EDC.HCl) (0.120 g, 
0.626mmol, 1.2 eq) was dissolved in DCM (15 mL). The EDC solution was added 
dropwise to the dye mixture. After the solution was stirred for 1 hour in the ice bath, 
the solution was left to stir for 16 hours at room temperature. The solution was washed 
using deionised water (2 x 40 mL), brine (2 x 40 mL) and dried with magnesium 
sulfate. The remaining solvent was removed in vacuo to obtain a yellow/orange solid. 
The crude product was purified by flash column chromatography, using a gradient 
from DCM to DCM with 5% methanol. Fractions containing the pure product were 
collected using the UV detector set to the dye at 398 nm. 
 
NTI * 
Yield: 67% 
1H NMR: (300 MHz, CDCl3-d) δ ppm, 8.63 (d, 1H, CH aromatic), 8.56 (d, 1H, CH 
aromatic), 8.44 (d, 1H, CH aromatic), 7.73 (t, 1H, CH aromatic), 7.25 (d, 1H, CH 
aromatic), 4.21 (t, 2H, -N-CH2-CH2-CH2), 4.04 (t, 4H, -N-CH2-CH2-O-), 3.29 (t, 4H, 
-N-CH2-CH2-O-, 2.84 (br s, 4H, N-Hydroxysuccinimidyl- CH2-CH2), 2.65 (t, 2H, -N-
O-CO-CH2- ), 1.83 (m, 4H, -N-CH2-CH2-CH2-CH2-CH2-), 1.56 (m, 2H, N-CH2-CH2-
CH2-CH2-CH2-). 
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2.7.7 Dye conjugation 
2.7.7.1 Conjugation of the pyrene dye to the cyclic peptide (4) 
 
 
Scheme 2.9 Synthetic route to the cyclic peptide-pyrene conjugate (CP-PYR) 
The deprotected cyclic peptide (3) (50 mg, 0.041 mmol, 1.0eq) was dissolved in DMF 
(300 µL). N,N-Diisopropylethylamine (DIPEA) (0.016 g, 0.124 mmol, 3.0 eq) was 
then added to the cyclic peptide solution and agitated for 30 minutes. 1-Pyrenebutyric 
acid N-hydroxysuccinimide ester (PYR) (0.019 g, 0.050 mmol, 1.2 eq) was then added 
to the CP base solution. The conjugation was reacted for 3 days at room temperature. 
The reaction was protected from light using aluminium foil. The solutions were 
purified via precipitation in ice-cold toluene. This was repeated three times. The 
remaining solvent was removed in vacuo. 
 
CP-PYR† 
Yield: 68% 
1H NMR: (500 MHz, TFA-d) δ ppm, 7.87-8.35 (m, 9H, Pyr aromatic CH), 7.68 (m, 
2H, Trp aromatic), 7.19-7.44 (m, 8H, Trp aromatic), 5.23 (m, 2H, Trp-α-H), 4.65-4.83 
(m, 6H, Leu-α-H, Lys-α-H), 3.50-3.72 (m, 6H, Trp CH2 + Lys CH2), 3.02-3.18 (m, 
4H, Lys(N3) CH2), 2.83-2.90 (m, 4H, Lys CH2, Lys(N3) CH2), 2.50 (m, 2H, Lys(N3) 
CH2), 1.70-2.01 (m, 28H, Lys(N3) CH2, Lys CH2, Leu aliphatic -CH -CH2), 0.83-0.94 
(m, 24H, Leu aliphatic CH3) 
MS (ESI-ToF): [M+Na]+ calculated 1498.84 and found 1498.75 
†Full analytics could not be completed due precious amount of compound.  
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2.7.7.2 Conjugation of the napthalimide dye to the cyclic peptide (5) 
 
Scheme 2.10 Synthetic route to the cyclic peptide-napthalimide conjugate (5). 
 
The cyclic peptide-napthalimide (CP-NTI, 5) was synthesised using the same 
procedure as the cyclic peptide-pyrene (CP-PYR, 4). 
 
CP-NTI† 
Yield: 77% 
1H NMR: (500 MHz, TFA-d) δ ppm, 8.85 (t, 2H, NTI aromatic CH), 8.73 (d, 1H, NTI 
aromatic CH), 8.23 (d, 1H, NTI aromatic CH), 8.10 (t, 1H, NTI aromatic CH), 7.05-
7.56 (m, 10H, Trp aromatic), 5.13 (m, 2H, Trp-α-H), 4.65-4.72 (m, 6H, Leu-α-H, Lys-
α-H), 4.55 (m, 4H, NTI - N-CH2-CH2-O-), 4.03 (t, 2H, NTI -N-CH2-CH2-CH2-), 4.19 
(m, 4H, NTI - N-CH2-CH2-O-),  3.37-3.57 (m, 6H, Lys CH2, Trp CH2), 3.15-3.34 (m, 
4H, Lys(N3) CH2), 2.75 (m, 4H, Lys CH2,  Lys(N3) CH2), 1.13-1.56 (m, 24H, Lys(N3) 
CH2, Lys CH2), 1.15-1.50, (m, 12H, Leu aliphatic -CH -CH2), 0.76-0.81 (m, 24H, Leu 
aliphatic CH3) 
MS (ESI-ToF): [M+Na]+ calculated 1606.89 and found 1606.83 
†Full analytics could not be completed due precious amount of compound.  
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2.7.8 Polymer conjugation 
2.7.8.1 Conjugation of the polymer to the cyclic peptide-dye via the pre-
functionalisation strategy 
 
Scheme 2.11 NHS-coupling of the strained alkyne (BCN-NHS) and linear PEG-amine 
(PEG-NH2) to form linear PEG with strained alkyne (PEG-BCN). 
The α-Methoxy-ω-amino PEG 20kDa (50 mg, 2.25 µmol, 1.0 eq) was dissolved in 
DMF (300µL). N,N-Diisopropylethylamine (DIPEA) (0.870 mg, 6.74 µmol, 3.0 eq) 
was then added to the PEG solution and agitated for 30 minutes. (1R,8S,9s)-
Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl carbonate (BCN-NHS) (7.85 mg, 
2.69 µmol, 1.2 eq) was then added to the solution. The conjugation was stirred 
overnight at room temperature. The reaction mixture was diluted with water, purified 
via dialysis (3 times) using centrifuge filter tubes and isolated via lyophilisation. This 
synthesis was repeated on a larger scale to obtain enough PEG - BCN for the polymer 
conjugation step. 
 
Scheme 2.12 Strained alkyne-azide coupling reaction to form the PEG-CP-PYR via 
the pre-functionalisation strategy 
The cyclic peptide-pyrene conjugate (CP-PYR, 4) (10 mg, 8.29 µmmol, 1 eq) was 
dissolved in DMSO (1.5 mL). N,N-Diisopropylethylamine (DIPEA) (3.22 mg, 0.025 
mmol, 3.0 eq) was then added to the CP-dye solution and agitated for 30 minutes. The 
strained alkyne modified PEG (PEG-BCN) (0.223 g, 9.95 µmol, 1.2 eq) was then 
added to the solution.  The conjugation was reacted for 3 days at room temperature. 
The reaction was protected from light using aluminium foil. The reaction mixture was 
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diluted with water, purified via dialysis (3 times) using centrifuge filter tubes and 
isolated via lyophilisation.  
The PEG-cyclic peptide-napthalimide (PEG-CP-NTI, 9) was also synthesised using 
the same procedure. 
Due to the inefficient coupling of the polymer to the cyclic peptide a negligible amount 
of compound was recovered. Characterisation of these compounds via the pre-
functionalisation polymer conjugation method was therefore not possible. 
2.7.8.2 Conjugation of the polymer to the cyclic peptide-dye via the post-
functionalisation strategy 
 
Scheme 2.13 Strained alkyne-azide coupling to form the NHS-functionalised cyclic 
peptide-pyrene conjugate (NHS-CP-PYR). 
The cyclic peptide-pyrene conjugate (CP-PYR) (30 mg, 0.020 mmol, 1 eq) was 
dissolved in DMSO (1.5 mL). N,N-Diisopropylethylamine (DIPEA) (7.88 mg, 
0.061 mmol, 3.0 eq) was then added to the CP-dye solution and agitated for 30 
minutes. The strained alkyne-NHS compound (BCN-NHS) (7.12 mg, 0.024 mmol, 
1.2 eq) was then added to the solution. The conjugation was reacted for 3 days at room 
temperature. The reaction was protected from light using aluminium foil. The 
solutions were purified via precipitation in ice-cold diethyl ether. The remaining 
solvent was removed in vacuo. 
 
Due to the limited amount of the NHS-CP-Dyes synthesised, characterisation of these 
compounds was extremely difficult. Therefore the presence of this intermediary 
compound was only confirmed via ESI-ToF mass spectrum. Attempts to check the 
purity of this compound via HPLC were not successful.  
 
NHS-CP-PYR (6)‡ 
MS (ESI-ToF): [M+Na]+ calculated 1789.9 and found 1789.9.  
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NHS-CP-NTI(7)‡ 
MS (ESI-ToF): [M+Na]+ calculated 1898.8 and found 1898.8 .  
 
Scheme 2.14 NHS-amine coupling reaction to form the cyclic peptide-polymer-dye 
conjugate (PEG-CP-PYR, 6). 
The α-Methoxy-ω-amino PEG 20kDa (PEG) (0.302 g, 0.014 mmol, 1.2eq) was 
dissolved in DMF. N,N-Diisopropylethylamine (DIPEA) (7.88 mg, 0.061 mmol, 3.0 
eq) was then added to the PEG solution and agitated for 30 minutes. The NHS-
functionalised cyclic peptide-pyrene conjugate (NHS-CP-PYR) (20 mg, 0.011 mmol, 
1.0 eq) was then added to the solution. The conjugation was reacted for 3 days at room 
temperature. The reaction was protected from light using aluminium foil. The reaction 
mixture was diluted with water, purified via dialysis (3 times) using centrifuge filter 
tubes (50 kDa) and isolated via lyophilisation. 
The PEG-cyclic peptide-napthalimide (PEG-CP-NTI, 9) was also synthesised using 
the same procedure. 
PEG-CP-PYR (8) 
Yield: 55% yield (assuming 100% yield of NHS-CP-PYR in the previous step) 
1H NMR: (500 MHz, DMF-d) was obtained (see appendix), some aromatic peaks can 
be observed, however assignment of this polymer conjugate was not possible due to 
the high molecular (20kDa) polymer attached to the CP. 
HPLC: see Figure 2.9 – shows one major peak and some minor impurities. Notably 
the conjugates were observed, using UV and fluorescence detectors, in the HPLC due 
to the improvement of their solubility after the conjugation of the PEG polymer. 
 
PEG-CP-NTI(9)† 
Yield: 59% yield (assuming 100% yield of NHS-CP-PYR after conjugation and 
purification) 
Chapter 2 
57 
 
1H NMR: see PEG-CP-PYR – spectra in the appendix 
HPLC: see PEG-CP-PYR – spectra in Figure 2.9.  
 
2.7.8.3 Dye conjugation of Cyanine dyes 
CP-Cy3 (4): The cyclic peptide 4 (20.0 mg, 1.66 x 10-5 mol, 1 eq.) was dissolved in 
DMF (0.5 mL) with the aid of sonication. To make certain the amine on the cyclic 
peptide was deprotected N,N-Diisopropylethylamine (DIPEA) (10 mgmL-1 stock 
solution in DMF, 0.64ml of stock solution, 6.4 mg, 4.98 x 10-5 mol, 3 eq.) was added. 
The solution was shaken for 30 minutes. The Cyanine3 NHS ester (11.6 mg, 1.99 x 
10-5 mol, 1.2 eq.) was then added to the solution and shaken overnight. The product 
was purified via precipitation using THF. Yield: 67% (18.5mg, 1.12 x 10-5 mol). ESI-
ToF, m/z (found) = 1644.9, (calculated) = 1645.0 ([M]+), see figure 2.10. HPLC (tR= 
24 mins) using Acetonitrile/Water gradient. Spectra can be found in Figure 2.9. 
 
CP-Cy5 (5): CP-Cy5 (5) was synthesised using the same protocol as CP-Cy3 (4). 
Cyanine5 NHS ester was used instead of Cyanine3 NHS ester to synthesise 5. Yield: 
29% (8.2 mg, 4.9 x 10-6 mol). ESI-ToF, m/z (found) = 1671.2, (calculated) = 1671.0 
([M]+), see figure 2.10. HPLC (tR= 24 mins) using Acetonitrile/Water gradient. 
Spectra can be found in Figure 2.9. 
 
2.7.8.4 Conjugation of pentanoic acid to the cyclic peptide 
CP-Alkyl (6): Pentanoic acid (2.7 µL, 2.49 x 10-5 mol, 3 eq.), HCTU (10.3mg, 2.49 x 
10-5 mol, 3 eq.) and N,N-Diisopropylethylamine (DIPEA) (6.43 mg, 4.97 x 10-5 mol, 
6 eq.) were dissolved together in DMF (1 mL) and shaken for 10 minutes. The cyclic 
peptide 4 (10.0 mg, 8.29 x 10-6 mol, 1 eq.) was separately dissolved in DMF (0.5 mL) 
with the aid of sonication. The pentanoic acid mixture was then added to the cyclic 
peptide solution. The resultant solution was shaken for 3 hours. The product was 
purified via precipitation using ice-cold diethyl ether. Yield: 61% (4.68 mg, 1.12 x 10-
5 mol). ESI-ToF, m/z (found) = 1312.5, (calculated) = 1312.8 ([M+Na]+), see figure 
2.11. Due to the insolubility of this compound HPLC was not possible. 
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2.7.8.5 NHS functionalisation of the cyclic peptide conjugates (CP-Cy3, CP-Cy5 
and CP-alkyl) 
NHS-CP-Cy3 (7): The CP-Cy3 (4) (18.5 mg) was dissolved in DMF (0.5 mL) with 
the aid of sonication. (1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl 
carbonate (BCN-NHS) was added to the cyclic peptide solution. The resultant solution 
was shaken overnight. The product was purified via precipitation using ice-cold 
diethyl ether. Yield: 73% (17.8 mg, 9.19 x 10-6 mol). ESI-ToF, m/z (found) =1936.0, 
(calculated) = 1936.1 ([M]+), see figure 2.10. HPLC (tR= 22 mins) using 
Acetonitrile/Water gradient. Spectra can be found in Figure 2.9. 
 
NHS-CP-Cy5 (8): NHS-CP-Cy5 (8) was synthesised using CP-Cy5 (5) and the same 
protocol as NHS-CP-Cy3 (7). Yield: 78% (7.9 mg, 4.0 x 10-6 mol). ESI-ToF, m/z 
(found) =1962.1, (calculated) = 1962.1 ([M]+), see figure 2.9. HPLC (tR= 22 mins) 
using Acetonitrile/Water gradient. Spectra can be found in the figure 2.10. 
 
NHS-CP-Alkyl (9): NHS-CP-Alkyl (6) was synthesised using CP-Alkyl (6) and the 
same protocol as NHS-CP-Cy3 (7). Yield: 74% (4.1 mg, 2.6 x 10-6 mol). Due to the 
insolubility of this compound ESI-ToF and HPLC was not possible. 
 
2.7.8.6 Conjugation of the polymer to the cyclic peptide 
PEG-CP-Cy3 (10): NHS-CP-Cy3 (7) (14mg) was dissolved in DMF (0.5mL) with 
the aid of sonication. α-Methoxy-ω-amino PEG 20 kDa (0.247 g, 1.08 x 10-5 mol, 1.5 
eq.) was added to the cyclic peptide solution. To make certain the amine on the 
polymer was deprotected N,N-Diisopropylethylamine (DIPEA) (10mg/mL stock 
solution in DMF, 0.24 ml of stock solution, 2.4 mg, 1.4 x 10-5 mol, 2 eq.) was added. 
The solution was shaken overnight. The product was purified using centrifuge dialysis 
tubes with a molecular weight cut-off of 50kDa. Yield: 58% (101 mg, 4.21 x 10-6 mol). 
HPLC (tR= 16 mins) using Acetonitrile/Water gradient. Spectra can be found in the 
Figure 2.9. 
 
PEG-CP-Cy5 (11): PEG-CP-Cy5 (11) was synthesised using NHS-CP-Cy5 (8) and 
the same protocol as PEG-CP-Cy3 (10). Yield: 67% (59.9 mg, 2.48 x 10-6 mol). HPLC 
(tR= 16 mins) using Acetonitrile/Water gradient. Spectra can be found in Figure 2.9. 
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PEG-CP-Alkyl (12): PEG-CP-Cy5 (12) was synthesised using NHS-CP-Alkyl (9) 
and the same protocol as PEG-CP-Cy3 (10). Yield: 56% (34.4 mg, 1.45 x 10-6 mol). 
HPLC (tR= 21 mins) using Acetonitrile/Water gradient. Spectra can be found in Figure 
2.9. 
2.7.8.7 Reactions schemes for the dye and polymer conjugations steps. 
Synthesis of PEG-CP-Cy3 
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Synthesis of PEG-CP-Cy5 
 
 
Synthesis of PEG-CP-Alkyl 
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2.8 Appendix 
 
Figure 2.14 1H NMR of linear peptide (1). See experimental for assignment. 
 
 
Figure 2.15 1H NMR of protected cyclic peptide (2). See experimental for assignment. 
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Figure 2.16 1H NMR of deprotected cyclic peptide (3). See experimental for 
assignment. 
 
 
Figure 2.17 1H NMR of NHS-functionalised NTI dye (NTI). See experimental for 
assignment. 
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Figure 2.18 1H NMR of cyclic peptide-pyrene (CP-PYR, 4). 
 
Figure 2.19 1H NMR of cyclic peptide-napthalimide (CP-NTI, 5). 
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Figure 2.20 1H NMR of PEG-cyclic peptide-pyrene (PEG-CP-PYR, 6). Due to the 
size of the PEG (20kDa) assignment of peak was not possible. 
 
 
Figure 2.21 1H NMR of PEG-cyclic peptide-napthalimide (PEG-CP-NTI, 7). Due to 
the size of the PEG (20kDa) assignment of peak was not possible. 
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Chapter 3 Investigating the Dynamic 
Behaviour of Self-Assembling Cyclic Peptide 
- Polymer Nanotubes in Solution and in 
Mammalian Cells 
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3.4 Introduction 
A key advantage of self-assembling cyclic peptides is their highly adaptable design. 
In the previous chapter, using a ‘bottom up’ approach, the synthesis and 
characterisation of asymmetric model conjugates to monitor the dynamic behaviour of 
these supramolecular systems were developed. These conjugates were designed to 
contain both a FRET dye and polymer on the periphery in order to directly infer the 
exchange of cyclic peptides between the nanotubular assemblies, see figure 3.1. 
In the following chapter, these systems will be used to prove the supramolecular 
nanotubes are dynamic - not kinetically trapped. Secondly, to gain a detailed 
understanding of what role the environment plays in the dynamics of these self-
assembling systems, key parameters such as solvent and concentration were also 
varied. Finally, the use of FRET allowed us to observe the behaviour of these 
nanotubes in mammalian cells in vitro, thus providing essential information about their 
dynamics in a complex biological environment. 
 
Figure 3.1 Schematic representation of the cyclic peptide-dye-polymer conjugates.  
 
  
Chapter 3 
68 
 
3.5 Results and Discussion 
3.5.1 Characterisation of the self-assembling cyclic peptide conjugates 
Hydrogen bonding between the amide bonds is known to drive the self-assembly of 
the CPNTs. However, the length of the formed nanotube can be influenced by number 
of different factors such as composition and position of the amino acids, as well as 
polymer grafting.1 Before the dynamics of these supramolecular systems could be 
inferred, it was important to fully characterise the nanotubular assembly of these 
peptides. Herein, the morphology of the resulting CP-polymer conjugates were 
analysed using small angle neutron scattering (SANS), Static Light Scattering (SLS) 
and Transmission Electron Microscopy (TEM).  
SANS is a powerful technique to characterise complex systems in order to understand 
any structural parameters, interactions, and changes due to environmental stimuli 
occurring in solution.2 Previously, our group has used SANS to analyse a wide-range 
of CPNTs in different solvents, polymer conjugations, and in response to different 
stimuli (pH and temperature).3-5 Here, SANS was used to confirm the formation of 
nanotubes for a mixture of conjugates PEG-CP-Cy3 16 and PEG-CP-Cy5 17, and to 
analyse how the presence of a fluorophore affected their stacking potential compared 
to the non-dye conjugated control (PEG-CP-Alkyl, 18).  
Figure 3.5a shows the reduced, corrected SANS scattering data for the control and the 
dye conjugated peptide system. From the fit, the length of each nanotube could be 
obtained. The data were initially fitted with either a cylinder or a core-shell cylinder 
model form factors, however, a statistically reliable fit was not obtained. As a result, 
a hairy-cylinder model was used that combines the form factors for a micelle with a 
rod-like core and attached flexible polymer chains, with a high degree of accuracy in 
both cases (Experimental section 3.4.2.3).  
The core-radius has been shown to be 0.34 nm in previous studies and was used as a 
fixed parameter in the fitting process.3 From the values obtained, the number of 
aggregation (Nagg) can be determined by dividing the length of the tube by the distance 
between two single cyclic peptide unimers (0.47 nm), shown in Table 1.3, 6 Visually 
analysing the scattering profiles reveals a major difference in the Guinier region (q = 
0.00416 - 0.01). Given that the Guinier region provides information on larger 
structures within the system, deviations here indicate nanotubes of different lengths. 
Chapter 3 
69 
 
The control has a higher intensity at q-1, suggesting the formation of longer nanotubes, 
which is demonstrated in the fits. The dye-conjugated peptide however, turns over, 
suggesting tubes of a finite length exist. The length of the tubes was found to be 117 
nm, compared to 89 nm for the control and mixed system, respectively. 
In addition to SANS, SLS experiments were used to determine the Nagg for the non-
dye conjugated system in a range of concentrations (Experimental section 3.4.2.8). 
The dye conjugates could not be measured directly as the wavelength of the laser used 
for SLS (633nm) overlaps with the dye excitations (570 nm and 646 nm for Cy3 and 
Cy5, respectively). The Nagg of non-dye conjugated system was then used as a floating 
variable in the fitting process.  
 
 
Figure 3.2 a) Reduced SANS scattering data for the PEG-CP-Alkyl (Control) and 
(Premixed) PEG-CP-Cy3 and PEG-CP-Cy5 system. The lines correspond to a fit to 
the hairy cylinder model. b) TEM image of cyclic peptide-polymer-dye conjugate 
(PEG-CP-Cy3) stained with UOAc. Distribution of nanotubular c) lengths and d) 
diameters extracted from TEM. 
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The data presented here clearly confirms that both the control (PEG-CP-Alkyl) and 
mixed systems (PEG-CP-Cy3 and PEG-CP-Cy5) form long nanotubular aggregates of 
similar size in situ. Discrepancy in the sizes can be attributed to the presence of the 
bulky and charged dye (Cy3 or Cy5). Yet, the variation remains minor, possibly due 
to the distance between the dye and the cyclic peptide created by the linker.  
Table 3.1 Summary on the characterisation of CPNTs using SANS and TEM. TEM 
values are represented as mean lengths and diameters ± standard deviation of 37 
individual nanotubes. 
*Premixed – PEG-CP-Cy3 and PEG-CP-Cy5 
Using TEM the nanotubular morphology observed in SANS was independently 
confirmed. Samples were prepared from pure water (1 mg/mL) using the drop casting 
method. The low electron density of the peptide-dye-polymer conjugates made 
obtaining TEM images of these compounds very challenging, thus negative staining 
of samples dropcast on thin (4 nm) carbon-coated copper grids was used. Images are 
presented in Fig 3.2b. The TEM images were kindly obtained by Liam R MacFarlane 
at the University of Bristol.  
The formation of one-dimensional structures can be seen for all three presented cyclic 
peptides (Figure 3.2B). Upon statistical analysis of the TEM images using ImageJ, a 
very narrow distribution with a mean diameter of 7.1 nm was determined for PEG-
CP-Cy3 (Figure 1D). This finding is consistent with the formation of single conjugated 
nanotubes. The diameter of the PEG-CP-Cy5 was relatively similar (mean diameter = 
8.4 nm), however a larger value was obtained for PEG-CP-Alkyl (mean diameter = 
15.5 nm). This could be associated to lateral aggregation upon removal of the solvent. 
The distribution of nanotube lengths was found to be wider (mean length = 85.0 nm 
for PEG-CP-Cy3, and 81.8 nm for PEG-CP-Cy5), which is to be expected in a self-
Sample Length 
(SANS)/  
nm 
Nagg 
(SANS) 
Length 
(TEM)/  
nm 
Nagg 
(TEM) 
Diameter 
(TEM)/ nm 
PEG-CP-Cy3 - - 85.0 (± 22.3) 180.9 7.1 (± 1.5) 
PEG-CP-Cy5 - - 81.8 (± 14.1) 174.0 8.4 (± 2.2) 
Premixed*  89.0 189.3 - - - 
PEG-CP-Alkyl 116.9 248.8 117.7 (± 32.0) 250.4 15.5 (± 3.7) 
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assembled system (Figure 3.5c). Distribution for PEG-CP-Cy5 and PEG-CP-Alkyl 
and can be found in Experimental section 3.4.2.10.  
3.5.2 Spectrochemical properties of dye conjugated cyclic peptides 
Following synthesis and characterisation, FRET was used to probe the dynamic nature 
of these supramolecular systems. The FRET emission of the acceptor dye (PEG-CP-
Cy5) only occurs when specific requirements are met. Firstly, the emission spectra of 
the donor (PEG-CP-Cy3) should overlap with the absorption spectra of the acceptor 
enabling the fluorescence of the donor to excite the acceptor. Unlike the pyrene and 
napthalimide dyes in Chapter 1, the Cyanine dye FRET pair Cy3 and Cy5 have an 
ideal spectral overlap and have been extensively used due to their high excitation 
coefficients and biocompatibility.7 The absorption and emission spectra of PEG-CP-
Cy3 and PEG-CP-Cy5 show that the conjugates conserve these properties (Appendix 
Figure 3.14 and 3.15, respectively).  Direct excitation of the acceptor dye in the 
subsequent FRET studies, which could also lead to acceptor emission, was 
circumvented by exciting the donor at 500 nm instead of its absorption maxima. 
Secondly, FRET will only take place if the donor and acceptor (Cy3 and Cy5 
respectively) are close enough in space for the energy transfer to take place, typically 
10-100 Å. The average distance between two CPs has previously been reported to be 
4.7 Å and the pore diameter of the CP around 7.5 Å.1, 8, 9 Therefore, an energy transfer 
for the presented system is expected if both dyes are incorporated into the same 
nanotube upon mixing. When these conditions are fulfilled, the energy transfer 
translates into a decrease in donor emission and an increase in the acceptor emission, 
see Figure 3.3. 
Here, FRET studies were carried out by comparing a mixture of PEG-CP-Cy3 and 
PEG-CP-Cy5, and a mixture of the free dyes in solution (Cy3 and Cy5) as a control. 
Mixing the dyes alone resulted in no change in the emission spectra over 30 minutes, 
which can be attributed to the dyes being too far from one another in solution (Figure 
3.3b). In comparison, the emission of PEG-CP-Cy5 increased and the emission of 
PEG-CP-Cy3 decreased over time upon mixing (Figure 3.3b). This behaviour is 
indicative of the formation of FRET pairs, resulting from the exchange of monomer 
units or small segments of peptide between the formed nanotubes. The increase over 
time indicates that CPs dynamically exchange between different nanotubes to form 
increasingly mixed nanotubes, as no self-assembly and exchange would result in no 
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FRET occurring. A schematic depiction of mixed cyclic peptide-polymer-dye 
conjugates can be found in Figure 3.4a.  
 
Figure 3.3 a) Schematic depiction of the FRET occurring in cyclic peptide nanotubes 
containing donor (Cy3) as well as acceptor (Cy5) dye molecules. b) Fluorescence 
donor and acceptor emission upon mixing the free dyes (Cy3 and Cy5) and the self-
assembling dye conjugates (PEG-CP-Cy3 and PEG-CP-Cy5) in water. 
3.5.3 Solvent dependent dynamic unimer exchange of CPNT 
Using the FRET system outlined above we can further probe the dynamics of the dye 
conjugates (PEG-CP-Cy3 and PEG-CP-Cy5) in a range of different solvent 
environments. Our group has previously shown that cyclic peptides form shorter 
nanotubes in more hydrogen bond competitive solvents.10 This is due to the solvent 
molecules competitively binding to the hydrogen bonding sites on the cyclic peptide 
required for stacking.  
In order to investigate these dynamics, stock solutions of PEG-CP-Cy3 (16) and PEG-
CP-Cy5 (17) were made in DMF, water and toluene which have a range of different 
properties. Emission spectra, upon mixing the dye conjugates (PEG-CP-Cy3 and PEG-
CP-Cy5) in a 1:1 volume ratio were taken at several different time intervals (Figure 
3.4b) until a plateau was reached. Emission was then expressed as a FRET ratio, 
calculated using equation 1.11, 12  
𝐸𝑟𝑒𝑙.  =  
𝐼𝐴
𝐼𝐷+𝐼𝐴
 (1) 
Where IA and ID are the total acceptor and donor fluorescence intensities respectively.  
Again, the change in emission associated with FRET (i.e. decrease in the donor and 
increase in the acceptor emission) was observed, with the exception of DMF, whereas 
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in water and toluene a clear increase can be observed, showing FRET is occurring.  
Interestingly, the rate at which FRET occurs appears to be different for both water and 
toluene (Fig 3.4c). In both solvents where conjugates are expected to assemble, the 
FRET ratio increases as a function of time, and therefore show the cyclic peptides 
dynamically exchanging to form progressively mixed nanotubes. This increase in 
FRET ratio eventually reaches a plateau whereby no further net mixing was observed 
and an equilibrium is maintained. The final FRET ratio of the equilibrium in different 
solvents clearly varies, and is postulated to be a result of the solvatochromic effects of 
the solvent, and/or the different lengths the nanotube assemblies. In addition, an 
insufficient exchange of CPs can lead to a lower final FRET ratio. The solvent 
dependent exchange kinetics were determined by modelling the increase in FRET ratio 
to a bi-exponential decay function, using OriginPro, providing two rate constants. A 
single exponential function yielded poor fits (R2 <0.9). Other FRET ratio kinetics in 
literature have also reported to require bi-functional models.11 This suggests that there 
are two different mixing processes occurring, an initial fast rate of mixing (k1) 
followed by a slower gradual exchange between assemblies (k2) until an equilibrium 
is reached. No rate constants could be determined for DMF as no increase over time 
was observed as the FRET ratio of < 0.l was reached instantaneously after mixing.  
 
Figure 3.4 a) Schematic depiction of the FRET studies. Preassembled individual 
cyclic peptide-dye-polymer conjugates in water (left) and a 1:1 mixture of both 
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conjugates after the assemblies are left to dynamically exchange (right). b) 
Fluorescence emission spectra of PEG-CP-Cy3 and PEG-CP-Cy5 upon mixing in 
water and c) Normalised FRET ratio of the mixed system in DMF, water and toluene. 
Toluene plateau was reached after 6 days (see Appendix Figure 3.17). 
In a highly hydrogen competitive solvent such as dimethylformamide (DMF), mainly 
unimeric species or small aggregates were expected,10 which is corroborated by the 
lack of change in FRET ratio upon mixing (Figure 3.4c), as they behave similarly to 
the non-assembling free dyes. The fluorescence emission of the donor stays obviously 
greater than the emission of the acceptor, lending itself to a low FRET ratio. In a 
disassembled/fully dynamic system the FRET ratio would not be expected to change. 
The FRET ratio observed remains constant, however it is not at zero due a small 
proportion of formed conjugates.  
In water, which is less hydrogen bond competitive than DMF, the solvent molecules 
can still compete with peptide-peptide hydrogen bonding, however to a far lesser 
extent than in DMF. The increase in FRET ratio (Figure 3.4c) shows that the dye 
conjugates are dynamically exchanging to form increasingly mixed tubular 
aggregates. The plateau reached after 3 hours shows that no further net mixing occurs 
after this point (Figure 3.4c). 
Surprisingly, this dynamic behaviour was also observed in toluene where the solvent 
is not expected to compete with the hydrogen bond stacking sites of the CP. As 
expected, the rate at which they exchange is far slower than in water (7 days (figure 
3.17) compared to 3 hours). In non-polar solvents the solvent molecules do not interact 
with the hydrogen bond sites on the cyclic peptide. For this reason, a slow rate of 
dynamics in toluene can be seen in both the kinetic rate constants (Table 3.2). A 
possible mechanism for this is that the nanotubes are breaking at different positions 
and reform instead of the exchange of unimers.13  
The maximum FRET ratio was determined by measuring a premixed system. This was 
prepared by first separately dissolving each dye conjugate in DMF and then mixing 
them in a 1:1 volume ratio. The solvent was then evaporated and the residual CP 
conjugates were re-dissolved in water or toluene (Max FRET ratio, in Table 3.2). This 
ensured that the nanotubes formed in solution would be random supramolecular 
copolymers of both compounds. The minor difference observed between the 
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maximum and final FRET ratio could be associated to the presence of small 
homogenous regions within the nanotubes. 
Table 3.2 The rate kinetics of the exchanging donor and acceptor conjugated cyclic 
peptide-polymer nanotubes. The final FRET ratio was the value at which the plateaux 
was reached.  
 
* The maximum FRET ratio was determined using a premixed sample dissolve in the 
respective solvent. See experimental section for details. 
In DMF, no emission change over time and a low FRET ratio indicates these conjugates 
resemble the free dyes which do not aggregate. 
 
A theoretical FRET ratio of 1 would be expected if the dye conjugates formed 
statically mixed tubes of infinite length. Shown in Table 3.2, the final FRET ratios 
observed do not reach 1, therefore, suggesting the length of the aggregates formed or 
the presence of unimers in solutions prevents a quantitative exchange. 
 
3.5.4 Concentration dependency of CPNT self-assembly 
The described FRET system was also used to study the effect of concentration on the 
assembly of the CPNTs. Using the premixed system in water, vide supra, the solution 
was systematically diluted to observe the influence of concentration on the nanotube 
assembly. The fluorescence acceptor emission of this solution was measured upon 
excitation at 500 nm (donor) and 677 nm (acceptor) independently. The FRET 
intensity was normalised against the maximum emission determined by direct 
excitation of the acceptor. As expected, the normalised FRET intensity decreased upon 
dilution (Figure 3.5b). Interestingly, at low concentrations, a plateau was reached, after 
which further dilution of the system showed no change in normalised FRET emission.  
Solvent k1/ s-1 k2/ s-1 Final 
FRET ratio 
Max 
FRET ratio* 
Degree of 
mixing/ % 
DMF - - 0.084 0.084 (100%) 
Water 96.12 3.80 0.729 0.810 90% 
Toluene 1.10 0.06 0.780 0.882 88% 
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Figure 3.5 a) Fluorescence emission concentration dependent study of the mixed 
nanotubes. The concentration dependence on the cyclic peptide (premixed PEG-CP-
Cy3 and PEG-CP-Cy5) stacking measured via b) fluorescence emission of the 
premixed dye conjugates and c) SLS of the control conjugates. 
Using static light scattering (SLS) the average molecular weight and Nagg of non-dye 
conjugates were studied in a similar concentration regime as the FRET study with the 
dye conjugates (Experimental section 3.4.2.8). This is corroborated by SANS which 
showed similar nanotubular lengths for the premixed dye and non-dye conjugates. A 
trend, whereby at lower concentrations a decrease in the number of aggregation, was 
observed in the SLS. It should be noted that these scattering experiments only yield 
relative information about these systems, as these values may be an effect of 
interactions between tubes at higher concentrations. Nevertheless, the relative 
observations of the polymerization process as observed from SLS supports the trend 
as obtained by FRET, whereby at lower concentrations smaller aggregates were 
formed (Figure 3.5c). Aggregation of the conjugates at lower concentrations could not 
be studied accurately using SLS due to insufficient intensity of scattered light using 
the instrument set-up.  
3.5.5 In vitro dynamic of cyclic peptide nanotubes 
Having characterised the dynamics of these model cyclic peptide-polymer conjugates 
in a controlled environment (i.e. pure water), we turned to studying their behaviour in 
a more complex setting, namely living biological systems. This biological study was 
completed by Raoul Peltier in our group at the University of Warwick. The peptides 
PEG-CP-Cy3 and PEG-CP-Cy5 were incubated in the presence of MDA-231 cells 
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(human breast adenocarcinoma) and fluorescence, including FRET-associated 
fluorescence, was observed using fluorescent confocal microscopy. PEG-CP-Cy3 was 
used in a higher concentration (12 µM) than PEG-CP-Cy5 (4 µM) to account for the 
lower intensity as a result of not exciting the dye at its absorption maximum, resulting 
in a total concentration of 16 µM peptide. Negative controls whereby the cells were 
incubated individually with either PEG-CP-Cy3 or PEG-CP-Cy5 for 150 minutes 
clearly showed intracellular fluorescence when excited at their respective dye 
absorption and observed at their respective dye emission (Figure 3.6). The vast 
majority of the fluorescence can be observed in the intracellular region close to the 
nucleus, in a punctuated design which indicates that the compounds have not diffused 
in the cytosol but remain trapped within the lysosomes instead. Endosomal uptake and 
subsequent localisation in the lysosomes is expected for such nanosized objects and 
has been demonstrated for similar structures.14 
When both PEG-CP-Cy3 16 and PEG-CP-Cy5 17 were co-injected and co-incubated 
in the presence of cells, allowing cyclic peptide-polymers to form mixed conjugates 
before or during cell entry, fluorescence associated with FRET could be observed 
within the cells. A similar result was observed when PEG-CP-Cy3 and PEG-CP-Cy5 
where premixed in DMF, dried, re-dissolved in water, and injected in the cell culture. 
These results indicate that synthesised nanotubes of mixed conjugates can enter cells 
via endocytosis and remain intact within the harsh environment of the lysosomes for 
the time of the study.  
Next, we wanted to test whether individual CPs could form mixed conjugates within 
the complex environment of living cells. We hypothesized that PEG-CP-Cy3 and 
PEG-CP-Cy5 nanotubes incubated separately with the cells could, given enough time, 
mix within the restricted environment of the lysosomes. By incubating PEG-CP-Cy5 
for 30 minutes, washing the cells thoroughly and further incubating with PEG-CP-
Cy3 for 120 minutes, a significant increase in the intracellular fluorescence associated 
with FRET as compared to the control was observed (Figure 3.6-3.7). This result 
clearly indicates that not only some of the nanotubes are transported into the same cell 
compartment but that the nanotubes are still able to exchange and re-organise 
themselves into mixed self-assembled systems within the cells. Taken together, the 
data demonstrate that this self-assembling system is robust enough to maintain its 
shape within a biological environment whereas the dynamic character is preserved 
Chapter 3 
78 
 
enabling different species of nanotubes to communicate with each other via the 
exchange of unimers. The compatibility of these nanostructures with living cells 
highlights the potential of these compounds for future biological and biomedical 
applications.  
 
Figure 3.6 Confocal microscopy imaging of MDA-231 cells incubated in the presence 
of either A) PEG-CP-Cy5 alone (4 µM); B) PEG-CP-Cy3 alone (12 µM); C) premixed 
PEG-CP-Cy5 (4 µM) and PEG-CP-Cy3 (12 µM); D) co-injected PEG-CP-Cy5 (4 µM) 
and PEG-CP-Cy3 (12 µM); E) PEG-CP-Cy5 (4 µM) for 30 minutes, washed and PEG-
CP-Cy3 (12 µM) for 120 minutes. Unless indicated otherwise, incubation proceeded 
for 150 min. Nucleus fluorescence was obtained using Hoechst 33342. 
Excitation/Emission used for measurement are as follow, nucleus channel (405 / 406-
Chapter 3 
79 
 
459 nm), donor channel (517 / 540-577 nm), acceptor channel (633 / 670-724 nm), 
FRET (496 / 675-800 nm).  
 
Figure 3.7 Average intensity of intracellular fluorescence associated with FRET, as 
calculated using the mean of fluorescence in each cells for a minimum of 15 cells.  
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3.6 Conclusion 
The FRET dyes on the periphery of self-assembling cyclic peptide nanotubes have 
enabled us to directly monitor the dynamic behaviour of these supramolecular 
polymers in a range of different environments. The change in fluorescence emission 
was used to not only prove that the self-assemblies were rapidly disassembling and 
reassembling but also infer their rate of exchange and extent of mixing. Previously the 
hydrogen bond competitivity of the solvent was shown to directly affect the 
aggregation number here we show this was also extremely important in governing the 
rate of exchange between nanotubes. Although in all cases near quantitative mixing is 
observed in comparison to premixed samples; the kinetics are much faster in aqueous 
solutions as compared to toluene - with the nanotubes almost fully mixing after 3 
hours. 
Further studies showed that upon dilution the fluorescence associated with the FRET 
decreased, which is related to a steady decrease in size of the aggregates, a trend 
confirmed via static light scattering. In complex environments such as living cells, the 
combination of FRET and confocal microscopy showed that the different nanotubes 
were independently transported into the same cell compartments addition of the 
individual FRET-dye conjugates. This ability to recombine even under such 
conditions as present in living cells makes these materials attractive as a basic system 
for tracking of transport pathways, especially as further ligands can easily be attached 
to the polymer chain.  
Overall, the obtained results provide the first fundamental information about the 
dynamic nature of these promising supramolecular systems in a range of different 
environments. From this understanding, the next chapter will focus on how we can 
improve the stability of these dynamic self-assemblies. This process of understanding 
and designing plays an integral part to realising the potential biological applications 
of these, and other, supramolecular polymers. 
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3.7 Experimental 
3.7.1 Materials 
Fmoc-protected amino acids and coupling agents were purchased from Iris Biotech 
GmbH. Cyanine3 NHS ester and Cyanine5 NHS ester were obtained from Lumiprobe 
GmbH, Germany. The amine functionalised PEG was purchased from Rapp Polymere. 
Pentanoic acid was purchased from Alfa Aesar (UK). 
All other chemicals stated were purchased from Sigma-Aldrich, (Gillingham, UK) 
unless otherwise stated. Solvents were purchased from several departmental suppliers 
– Honeywell, Fisher and Sigma Aldrich. 
 
3.7.2 Characterisation 
3.7.2.1 Nuclear magnetic resonance spectroscopy (NMR)  
1H NMR spectrum were measured using a Bruker DPX-300 or DPX-400 NMR 
spectrometer which operated at 300.13 and 400.05 MHz respectively. The residual 
solvent peaks were used as internal references. Deuterated trifluoroacetic acid (d-
TFA) (δH = 11.5 ppm) was used to measure the peptides.  
3.7.2.2 Size-exclusion chromatography (SEC) / Gel permeation chromatography 
(GPC)  
GPC was measured using an Agilent PL50 instrument with a differential refractive 
index (DRI) detector. The instrument contained two PolarGel D columns (linear MW 
operating range: 200 to 400,000 g/mol (PS equivalent)) and a PolarGel 5μm guard 
column. DMF with 0.1% LiBr additive was used as the eluent. The system ran at 1mg 
min-1 (50ºC), with an injection volume of 100 μL. The samples were prepared by 
filtering them through 0.22 μm pore size membranes, before injection. Agilent 
EasyVial poly (methyl methacrylate) standards were used to calibrate the instrument 
and output data was analysed using Agilent GPC/SEC software.  
3.7.2.3 Small Angle Neutron Scattering (SANS) 
SANS was carried out on the Sans2d small-angle diffractometer at the ISIS Pulsed 
Neutron Source (STFC Rutherford Appleton Laboratory, Didcot, U.K.).15, 16  A 
simultaneous Q-range of 0.0045 – 0.7 Å-1 was achieved utilizing an incident 
wavelength range of 1.75 – 16.5 Å and employing an instrument set up of L1=L2=4m, 
with the 1 m2 detector offset vertically 60 mm and sideways 100 mm.  Q is defined as: 
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𝑄 =
4𝜋 sin
𝜃
2
𝜆
               (2) 
where θ is the scattered angle and λ is the incident neutron wavelength.  The beam 
diameter was 8 mm.  Each raw scattering data set was corrected for the detector 
efficiencies, sample transmission and background scattering and converted to 
scattering cross-section data (∂Σ/∂Ω vs. Q) using the instrument-specific software.17 
These data were placed on an absolute scale (cm-1) using the scattering from a standard 
sample (a solid blend of hydrogenous and perdeuterated polystyrene) in accordance 
with established procedures.18  
 
Following data acquisition, the SASfit software programme was used to model the 
data.  In all cases several fixed parameters were used; concentration, the radius of the 
core, and SLD values (for the solvent, core peptide, and polymer shell). 
Values for SLD were calculated using the following equation; 
𝑆𝐿𝐷 =
𝜌𝑁𝑎 ∑ 𝑏𝑖
𝑁
𝑖=1
∑ 𝑀𝑖
𝑁
𝑖=1
 
Where ρ is the bulk density of the material, Na is Avogadro’s constant, bi is the 
scattering length contributions from the N atoms within the unit cell, and M is the 
atomic mass of N atoms.  Values for individual atomic scattering lengths and atomic 
weights were taken from the NIST database.19, 20 SLD parameters were calculated for 
the solvent, polymer, and peptide and used as fixed values in the fitting analysis.  The 
use of data from previous SANS experiments provided the vale for cylinder radius of 
0.4 nm.    
The hairy-cylinder model, is a combination model adapted from the form factor of a 
micelle, with a rod-like core as an additionally structure factor.  The form factor can 
be described as; 
𝑃(𝑞) =  𝑁2𝛽𝑠
2𝐹𝑠(𝑞) + 𝑁𝛽𝑐
2𝐹𝑐(𝑞) + 2𝑁
2𝛽𝑠𝛽𝑐𝑆𝑠𝑐(𝑞) + 𝑁(𝑁 − 1)𝛽𝑐
2𝑆𝑐𝑐(𝑞) 
Where N is the aggregation number, and 𝛽𝑠 = 𝑉𝑠 (𝜌𝑠 − 𝜌𝑠𝑜𝑙𝑣) / 𝛽𝑐 = 𝑉𝑐 (𝜌𝑐 − 𝜌𝑠𝑜𝑙𝑣) 
is the total excess scattering lengths of the cylindrical core and in the corona, 
respectively. Vs and Vc are the volumes of the core and in the corona, respectively.  𝜌 
s and 𝜌c are the corresponding scattering length densities and 𝜌solv is the scattering 
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length density of the surrounding solvent, calculated as previously discussed. Table 
3.3 provides a summary of the fitting parameters.  Columns marked * were fixed 
variables. 
 
Table 3.3 Parameters and results from fitting the SANS scattering data to a hairy-
cylinder model. 
The individual fits (Fig 3.8 and 3.9) were considered statistically reliable when a Chi2 
of <30 was achieved. 
Following data acquisition, the SASfit software programme was used to model the 
data.  In all cases several fixed parameters were used; concentration, the radius of the 
core, and SLD values (for the solvent, core peptide, and polymer shell). 
Values for SLD were calculated using the following equation; 
𝑆𝐿𝐷 =
𝜌𝑁𝑎 ∑ 𝑏𝑖
𝑁
𝑖=1
∑ 𝑀𝑖
𝑁
𝑖=1
 
Where ρ is the bulk density of the material, Na is Avogadro’s constant, bi is the 
scattering length contributions from the N atoms within the unit cell, and M is the 
atomic mass of N atoms.  Values for individual atomic scattering lengths and atomic 
weights were taken from the NIST database.19, 20 SLD parameters were calculated for 
the solvent, polymer, and peptide and used as fixed values in the fitting analysis.  The 
use of data from previous SANS experiments provided the vale for cylinder radius of 
0.4 nm.    
Sample Length of 
nanotube 
(nm) 
Nagg Rg (nm) *Core 
radius 
(nm) 
*SLD 
peptide 
(cm-1) 
*SLD 
polymer 
(cm-1) 
Cy3/Cy5 
mixed 
88.98 189.32 93.43 0.34 5.09E-7 6.78E-7 
PEG-
conjugated 
control 
116.93 248.79 113.12 0.34 5.09E-7 6.78E-7 
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The hairy-cylinder model, is a combination model adapted from the form factor of a 
micelle, with a rod-like core as an additionally structure factor.  The form factor can 
be described as; 
𝑃(𝑞) =  𝑁2𝛽𝑠
2𝐹𝑠(𝑞) + 𝑁𝛽𝑐
2𝐹𝑐(𝑞) + 2𝑁
2𝛽𝑠𝛽𝑐𝑆𝑠𝑐(𝑞) + 𝑁(𝑁 − 1)𝛽𝑐
2𝑆𝑐𝑐(𝑞) 
Where N is the aggregation number, and 𝛽𝑠 = 𝑉𝑠 (𝜌𝑠 − 𝜌𝑠𝑜𝑙𝑣) / 𝛽𝑐 = 𝑉𝑐 (𝜌𝑐 − 𝜌𝑠𝑜𝑙𝑣) 
is the total excess scattering lengths of the cylindrical core and in the corona, 
respectively. Vs and Vc are the volumes of the core and in the corona, respectively.  𝜌 
s and 𝜌c are the corresponding scattering length densities and 𝜌solv is the scattering 
length density of the surrounding solvent, calculated as previously discussed. 
The individual fits (Fig 3.8 and 3.9) were considered statistically reliable when a Chi2 
of <30 was achieved. 
 
Figure 3.8 Reduced scattering data and fit to a hairy cylinder model for the premixed 
PEG-CP-Cy3 and PEG-CP-Cy5. 
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Figure 3.9 Reduced scattering data and fit to a hairy cylinder model for the control 
PEG conjugated cyclic peptide (PEG-CP-Alkyl). 
 
3.7.2.4 Ultraviolet/visible (UV-Vis) absorption spectroscopy  
UV-Vis absorption spectra was measured using an Agilent Technologies Cary 60 UV-
Vis spectrometer. The UV spectra of PEG-CP-Cy3 (16) and PEG-CP-Cy5 (17) were 
obtained in each solvent (water, DMF, toluene). The solution were all made to the 
same concentration (35 µM). Spectra can be found in Appendix Figure 3.14. 
 
3.7.2.5 Fluorescence emission spectroscopy  
Fluorescence emission spectra was measured using an Agilent Technologies Cary 
Eclipse Fluorescence spectrometer. The FRET studies were performed using an 
excitation wavelength of 500 nm. This was done to significantly reduce the direct 
excitation of the acceptor in the FRET studies. The acceptor emission upon excitation 
at 500 nm was considerably smaller than at 548nm (absorption maxima of the donor). 
See Appendix Figure 3.15 for the emission spectra of the conjugates 16 and 17. 
 
Dynamics in self-assembled systems: First, 35 µM stock solutions of PEG-CP-Cy3 
and PEG-CP-Cy5 were prepared in the water. The emission spectra of the PEG-CP-
Cy3 was measured before the addition of the PEG-CP-Cy5 conjugate. The 
fluorescence emission spectra were taken using the Agilent Kinetic software. 
Excitation of the donor was set to 500 nm, donor emission (detected) to 565 nm and 
Chapter 3 
86 
 
acceptor emission (detected) at 662 nm. The mixing of the dyes Cy3-NHS and Cy5-
NHS were also tested using the same conditions. 
 
Solvent dependence study: First, 35 µM stock solutions of PEG-CP-Cy3 and PEG-CP-
Cy5 were prepared in the relevant solvent. The emission spectra of the PEG-CP-Cy3 
was measured before the addition of the PEG-CP-Cy5 conjugate. The fluorescence 
emission spectra were taken at several time points upon the addition of the PEG-CP-
Cy5. The FRET ratio was obtained using the equation 1, the relative FRET intensities 
were calculated and fitted to a second order exponential function. 
 
Concentration dependence study: First, 50 µM stock solutions of PEG-CP-Cy3 and 
PEG-CP-Cy5 in DMF were prepared. 1 mL of each stock solution was added to a vial 
and the solution was shaken for 30 minutes and the solvent was evaporated. The 
residual solid was then redissolved in a precise volume of water (around 1 mL) to 
create a dye conjugate solution with a concentration of 100 µM. 1 mL of this solution 
was transferred to measure the first concentration (100 µM). Next, 1 mL of water was 
added to the cuvette to yield the next dilution (50 μM). For subsequent concentrations 
the solution in the cuvette was transferred to another vial and further dilution 
concentrations were made up in a new vial using 1 mL of water and 1 mL of the 
transferred (previous) solution. 
 
3.7.2.6 High performance liquid chromatography (HPLC)  
High performance liquid chromatograms (HPLC) was measured using an Agilent 
Technologies 1200 Series, equipped with a Luna 5u C18 100 Å, 250 x 4.6mm column. 
Acetonitrile/Water were used. All solvents contained 0.04 vol% TFA. See table below 
for the method and gradients. 
 
Table 3.4 HPLC gradient method 
Time/ mins Acetonitrile/ % Water/ % 
0-5 10 90 
5-35 10 to 95 95 to 10 
35-38 95 5 
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3.7.2.7 Mass spectrometry (ESI-TOF)  
Electronspray ionisation (ESI) – time of flight (TOF) mass spectra (MS) was measured 
using a Bruker MicroTOF to characterise the peptides and peptide conjugates. The 
instrument can achieve less than 5 ppm mass accuracy. 
3.7.2.8 Static Light Scattering (SLS) 
The SLS data were obtained using the ALV/CGS-3 Compact Gonimeter System.  
A range of different concentrations of non-dye conjugated CP-polymers measured 
using SLS. The compounds were first accurately measured in a vial and corresponding 
volumes of water were added to yield various different concentrations (5 mg mL-1 - 
0.2 mg mL- 1). Before measuring, the solutions were filtered using 0.2 µM membrane 
PTFE lined filters to remove any large PEG crystalline aggregates. 
 
Figure 3.10 Evolution of KC/R of PEG-CP-Alkyl in water as a function of q² obtained 
by static light scattering. 
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Figure 3.11 Evolution of 1/Ma of PEG-CP-Alkyl in water as a function of 
concentration obtained by static light scattering. 
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3.7.2.9 Confocal microscopy 
MDA-231 (human breast adenocarcinoma) cells were cultured in High Glucose 
DMEM medium supplemented with 10% fetal bovine serum. For confocal 
microscopy, MDA-231 cells were seeded in an 8-well ibidi plate at a density of 10 000 
cells per well and allowed to grow for 48 hours prior to the experiment. Cells medium 
was then replaced by fresh medium and supplemented with PEG-CP-Cy5 (4 µM), 
PEG-CP-Cy5 (12 µM), or both, from stock solutions at 200 µM in water. For the 
premixed sample, stock solutions of PEG-CP-Cy5 (200 µM) and PEG-CP-Cy5 (600 
µM) were prepared in DMF, sonicated, DMF evaporated with N2 flow and re-
dissolved in water. Cells were incubated with conjugates for 135 minutes. In the case 
of sequential incubation, PEG-CP-Cy5 (4 µM) was incubated first for 30 minutes, the 
cells washed thoroughly with PBS, then incubated with fresh media and PEG-CP-Cy5 
(12 µM) for 105 minutes. For all sample, Hoechst 33342 was then added and 
incubation proceeded for another 15 minutes before cells were washed with warm 
media twice. Confocal microscopy images were taken on a Leica TCS SP5 (Carl Zeiss, 
Germany) at a temperature of 37°C, using sequential scanning for each channel.  
Excitation/Emission used for measurement are used as follow: nucleus channel (405 / 
406-459 nm), donor channel (517 / 540-577 nm), acceptor channel (633 / 670-724 
nm), FRET (496 / 675-800 nm). Average of fluorescence for each sample was 
measured using ImageJ software by isolating single cells as region of interest and 
averaging the mean of fluorescence in each cells, on a minimum of 15 cells by 
samples. 
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3.7.2.10 Transmission Electron Microscopy (TEM)  
Carbon films (4 nm) were prepared on freshly cleaved mica sheets using a Quorum 
Q150T Turbo carbon coater. These films were deposited on copper TEM girds (mesh 
400 – Agar Scientific) by flotation water. Solutions of PEG-CP-dye/alkyl conjugates 
in water at 1 mg mL-1 were prepared by direct dissolution of the solid in filtered ultra-
pure water. Samples were left to age for 24h at room temperature then filtered through 
PTFE syringe filters (0.45 μm pore size). 10 μL of each solution was drop-cast on 
freshly glow-discharged carbon-coated grids placed on filter paper. After drying, 10 
μL of a 2% uranyl acetate solution in ethanol was dropped onto the grids on filter 
paper and left to dry. Bright field TEM micrographs were obtained with a JEOL 1400 
microscope operating at 120 kV, equipped with a Gatan digital camera. 
 
Figure 3.12 TEM images of PEG-CP-Cy5 (17). 
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Figure 3.13 TEM of PEG-CP-Alkyl (18).  
 
TEM of the PEC-CP-Cy3 conjugates in Figure 3.2b. 
Using ImageJ software the following length and diameter distributions were 
calculated. 
Due to the effect of drying and low contrast in these pictures it was difficult to 
determine exact diameter and length values.  
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3.8 Appendix 
 
Figure 3.14 Ultraviolet (UV) spectra of PEG-CP-Cy3 and PEG-CP-Cy5 in a) 
dimethylformamide, b) water and c) toluene at 17.5µM. 
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Figure 3.15 Fluorescence emission spectra of PEG-CP-Cy3 and PEG-CP-Cy5 in a) 
dimethylformamide, b) water and c) toluene at 17.5µM. 
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Figure 3.16 Fluorescence emission spectra of the FRET mixing study in a) 
dimethylformamide, b) water and c) toluene. 
 
The fluorescence emission spectra of the mixed PEG-CP-Cy3 (17.5 µM) and PEG-
CP-Cy5 (17.5 µM) were together taken at different times.  
 
 
 
A 
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Figure 3.17 The kinetic exchange of PEG-CP-Cy3 and PEG-CP-Cy5 upon mixing in 
toluene.  
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Figure 3.18 Normalised SEC trace of the initial PEG polymer before conjugation and 
the fully functionalised PEG-CP-Alkyl control conjugate.  
 
Note. Deconvolution of the higher molecular distribution was attempted however was 
not possible.  
(SEC: DMF +0.1% LiBr). 
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4.1 Introduction 
Proteins play a vital role in all living systems, from the catalysis of metabolic reactions 
to providing structure of our cells. Since the hierarchical self-assembly of proteins was 
elucidated, these fascinating molecules have been the subject of a host of biological 
applications. The amino acid building blocks of the peptide (primary structure) 
determine how the sequence will non-covalently fold and interact with itself 
(secondary and tertiary structure) and other peptides (quaternary structure). Nucleases, 
tubular proteins such as the tobacco mosaic virus and the collagen of our connective 
tissues all use this hierarchical assembly to form their impressive complex and defined 
nanostructures. Although synthetically reproducing the complexity of these systems 
is still a far prospect, the advent of supramolecular polymers has brought us a step 
closer by providing us with a powerful tool to synthesise a range of different 
morphologies on the nanoscale, such as nanofibers,1 nanoribbons2 and nanotubes.3, 4   
The transfer of supramolecular materials into applications requires a good 
understanding of their dynamic behaviour to avoid unexpected de-polymerization or 
aggregation. In the previous chapters the exchange behaviour of CPNT in water and 
in vitro showed the peptide unimers rapidly exchange between the self-assembled 
nanotubes.5 The highly dynamic nature of these supramolecular assemblies explains 
why many of these systems are very short in length, typically around 10 nm.6, 7 The 
hydrophilic polymer arms decorating the peptide nanotube provide a steric barrier to 
prevent lateral aggregation and in turn improve their solubility in water, however 
dramatically lower their aggregation number.8, 9  
The next generation of bio-inspired nanomaterials aims to encompass multiple design 
features, including controlled size, stability, bio-compatibility and high functionality. 
There are only a few examples of stabilised elongated uniform self-assembled 
nanostructures using the concept of ‘living’ supramolecular polymerization, discussed 
in detail in Chapter 1 (Introduction). Despite these incredible advances, designing 
controlled self-assembly systems for biological relevant systems in aqueous 
conditions has been much more challenging.   
Inspired by the hierarchical design and structure of proteins, a two-fold self-assembly 
approach was developed to help stabilise the elongated peptide nanostructure. The 
hydrogen bond stacking of the cyclic peptides provides the primary structure and 
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overall cylindrical morphology of the self-assembled aggregates. Here we introduce a 
secondary structural driving force in the form of a hydrophobic region around the 
peptide to stabilise the single cyclic peptide nanotubes. The individual nanotubes 
remain independent due to the hydrophilic corona stabilising the nanostructures in 
water. This hierarchical approach offers a method to stabilise, not only cyclic peptides, 
but other β-sheet forming self-assembled architectures. The increasing complexity of 
these systems is the next step to realising the biological applications of these promising 
synthetic supramolecular polymers.   
4.2 Synthesis and Characterisation. 
4.2.1 Design and synthesis of CP-diblock polymer conjugates. 
In order to stabilise and improve the self-assembly of cyclic peptide–polymer 
nanotubes, an amphiphilic diblock co-polymer was attached to the periphery of the 
CP. As sterically demanding polymers have been shown to dramatically destabilise 
the nanotubes8 less bulky monomers such as butyl acrylate (BA) and N,N-
dimethylacrylamide (DMA) were chosen to form the hydrophobic and hydrophilic 
blocks, respectively. In order to form discrete regions around the cyclic peptide core 
(Figure 4.1), reversible addition fragmentation chain-transfer (RAFT) polymerisation 
was employed to generate narrow dispersity (Ð < 1.15) diblock co-polymers.10, 11 A 
homopolymer of the hydrophilic monomer of the same chain length (i.e. degree of 
polymerisation) lacking the hydrophobic region was also synthesised as a control. See 
Figure 4.2 
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Figure 4.1 Self-assembling cyclic peptide-diblock polymer conjugates. In aqueous 
conditions, the diblock copolymers conjugated onto the cyclic peptide (CP-(pBA-b-
pDMA)2) self-assembles to form a hydrophobic region around the peptide and a 
hydrophilic corona.  
 
Figure 4.2 SEC traces of the polymers: a) pBA and pBA-block-pDMA in THF and 
b) pDMA in DMF + 0.1% NH4BF4. 
Chapter 4 
103 
 
A CP with two conjugation sites was chosen to provide a dense hydrophobic core 
region around the peptide to better exclude water molecules competing with the 
hydrogen bond stacking of the nanotubes. The amine units of lysine were used to 
provide the handles for post-reaction modification of the peptide with the desired 
polymers. In the size exclusion chromatography (SEC) trace, a clear double molecular 
weight shift between the free polymer and the two-arm cyclic peptide-polymer 
conjugate was observed (see Figure 4.3). In the reaction mixture, containing both the 
conjugate and excess polymer, two distributions are visible. After purification via 
precipitation the lower molecular weight distribution associated with unconjugated 
polymer is removed. A conjugate with a similar degree of polymerisation, but without 
a hydrophobic region, was also synthesised as a control. The detailed synthetic 
procedure is given in experimental 4.6.3. For ease, the CP-(pBA-b-pDMA)2 and CP-
(pDMA)2 are referred to as the diblock or control conjugate, respectively. 
 
Figure 4.3 SEC traces of the polymer before conjugation and after conjugation. a) 
pBA-b-pDMA and CP-(pBA-b-pDMA)2 and b) pDMA and CP-(pDMA)2 in DMF 
+0.1% LiBr. 
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4.2.2 Characterisation of the diblock and control conjugates 
Next, the morphology, dimensions, toxicity and self-assembly mechanism of these 
self-assembling cyclic peptide-polymer nanotubes were investigated. In transmission 
electron microscopy (TEM), we observed the elongated morphology of diblock 
conjugated CP, with an average length of 210 nm calculated for diblock conjugates 
prepared in water at 1 mg mL-1.  
 
Figure 4.4 Characterisation of cyclic peptide-polymer nanotubes. a) TEM image 
of the diblock conjugates prepared in water. b) SANS profiles of the diblock and 
control conjugates fitted to a cylindrical micelle model using SASfit software. c) Table 
of the average length of the nanotubes measured via TEM, SANS and SLS 
respectively. 
As expected, it was not possible to observe the self-assemblies of the fully hydrophilic 
control conjugate in TEM due to their size (around 12 nm in SLS, vide infra).6-8 Small 
angle neutron scattering (SANS) was used to corroborate the nanotubular morphology 
of the peptide nanotubes in solution. Using SASfit software, the scattering profile of 
the diblock and control conjugates in D2O were best fitted to a cylindrical micellar 
model. The resulting fits showed the average length to be over 100 nm (the size 
window available to SANS analysis) for the diblock conjugate, and 10 nm for the 
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control conjugates (Figure 4.4c). A detailed analysis of the SANS fitting and 
experimental is given in experimental 4.6.6.  
The aggregate length and the number of participating unimers of the control conjugate 
were determined using static light scattering (SLS) as 12 nm and 25 respectively. The 
aggregation number (Nagg) was calculated by dividing the average molecular weight 
of the aggregate, obtained by SLS, with the molecular weight of the unimer. The 
theoretical spacing of 0.5 nm between the cyclic peptides12 in the nanotubes was used 
to extrapolate the average length of the nanotubes (i.e. Nagg  0.5 nm). The nanotubular 
length of the diblock conjugate solutions prepared at 1 mg mL-1 were consistently 
higher than the control conjugates - see Figure 4.4c and 4.6.5 for details. 
The fluorescent dye, 1,6-diphenylhexatriene (DPH),13 which is quenched in water, was 
employed to confirm the hydrophobic region at the core of the nanotubes. Figure 4.8, 
depicted in section 4.6.4, shows the fluorescence of the DPH observed for the diblock 
conjugate, but not for the control conjugate, which does not have a hydrophobic 
region. 
The diblock and control conjugates were tested for bio-compatibility using the 2,3-
bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay. 
PC-3 cells (epithelial prostate cancer cells) were treated over 24 hours with the 
conjugates. The assay was used to examine the viability of the cells in the presence of 
the nanotubes. Both diblock and control conjugate showed no toxicity (0.1 – 100 µM, 
see experimental Figure 4.12). This XTT assay was carried out by Sean Ellacott in the 
Perrier group at the University of Warwick. 
4.3 Dynamics of diblock conjugated cyclic peptide nanotubes 
To study the stability of these nanotubes we determined their average size via SLS, 
after subjecting them to sonication for 1 hour. The samples were then left to stand and 
SLS was remeasured both after 1 hour and after 3 days. In a dynamic system, the 
reduction of Nagg, caused by the sonication will be corrected if the systems is left to 
equilibrate. This would result in a return to the original, and most thermodynamically 
stable, aggregation number. In a kinetically trapped, non-dynamic system, any 
decrease in the Nagg due to sonication will remain relatively unchanged over time, due 
to the high stability of the assemblies. Therefore, the difference in tubular length 
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between the original assemblies and the sonicated structures can be used as a measure 
for kinetic lability of CPNT-polymer conjugates. 
 
Figure 4.5 Dynamics of cyclic peptide-polymer nanotubes. The calculated length of 
the nanotubes from SLS over a range of concentrations (0.1 – 3.0 mg mL-1) before 
and after sonication. 
As shown in Figure 4.5, the aggregation number of the diblock conjugates was 
significantly reduced after sonication across all concentrations. Indeed, at 1 mg mL-1, 
the average length of the original nanotubes was found to be 273 nm while, after 
sonication, values of 94 nm and 89 nm were measured after being left to stand for 1 
hour and 3 days respectively. Conversely, no change was observed for the control 
conjugates, which were 11, 14, 10 nm before and after sonication (1 hour and 3 days 
after they were left to stand) – Table 4.2. This corroborates our hypothesis that the 
hydrophobic region helps to stabilise the peptide self-assembly and reduces the 
dynamic nature of these systems.14 In contrast, the hydrophilic control conjugates 
which are highly dynamic are able to equilibrate rapidly to their original 
thermodynamically favourable state, explaining why no net change in Nagg is observed. 
To provide further insight into the dynamic behaviour of these supramolecular 
assemblies, Förster resonance energy transfer (FRET) dyes were conjugated to the 
periphery of the cyclic peptide-polymer nanotubes, to probe the rates of exchange of 
these systems. Using orthogonal amine protecting groups, selective deprotection of 
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the amine was used to first attach the dye, then polymers to the peptide.5 A detailed 
synthetic protocol and characterisation are given in experimental section 4.6.3. 
 
Figure 4.6 Kinetics of cyclic peptide-polymer nanotubes. a) The orthogonal 
functionalization of cyclic peptide (CP) with two polymer arms and a donor or 
acceptor FRET dye. b) Schematic of stable non-exchanging CP-polymer nanotubes. 
c) Scheme of dynamically exchanging mixed CP-polymer nanotubes. d) Rate 
constants for FRET exchange, final and maximum FRET ratio and degree of mixing 
for the free dye, diblock and control conjugates. Rate constants were determined by 
fitting to a second order decay function, see experimental section 4.6.11. Final FRET 
ratio was reached for the diblock and control conjugates after 7 days and 60 minutes 
respectively e) Graph to show the change in FRET ratio over time measured using 
fluorescence spectroscopy.  
Cyanine (Cy) 3 (FRET donor) and Cy5 (FRET acceptor) were chosen as the FRET 
pair to detect the mixing of cyclic peptide conjugate unimers between nanotubes, see 
Figure 4.6a. If the Cy3 and Cy5 dyes are in close in proximity to one another, upon 
excitation of the donor dye, we should observe the emission of the acceptor dye due 
to energy transfer between the FRET pair.15 This proximity-dependent energy transfer 
can only take place when two different dye conjugates are assembled together in the 
same nanotube (each cyclic peptide is around 7.5 Å in diameter and the distance 
between the two peptides is 4.5 Å; the FRET range is between 10 to 100 Å), see Figure 
4.6b.16, 17 A control study with free dyes shows a constant FRET ratio (0.14) and no 
change in donor or acceptor emission over time is observed (Figure 4.6e).  
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Each unimer contains one dye molecule (either Cy3 or Cy5). Independently, Cy3 and 
Cy5 conjugates were pre-assembled in water and then co-injected together. If the 
cyclic peptides are highly dynamic, i.e. they disassemble and re-assemble readily, they 
form progressively mixed nanotubes. As donor and acceptor dyes come in closer 
proximity with every exchange, the FRET emission increases over time. This process 
should eventually lead to a statistically mixed nanotube where the Cy3 and Cy5 
modified peptide should be randomly distributed throughout the aggregate and a 
constant final FRET ratio is reached.  
Notably, in the control conjugate the increase in FRET ratio was very fast and the 
plateau (no net change in FRET ratio) was reached within 60 minutes – as expected 
for a highly dynamic system. In contrast, the change in FRET ratio is extremely slow, 
when the diblock conjugates are co-injected. To elucidate a maximum for the FRET 
ratio for both systems, another control experiment was set up. The conjugates were 
premixed in DMF, where they primarily exist as unimers. The DMF was removed and 
the conjugates were resuspended in water to measure the maximum FRET ratio of 
statistically mixed nanotubes, see Figure 4.6d. A percentage degree of mixing was 
calculated by comparing the final FRET ratio (at the plateau) to the maximum FRET 
ratio from statistically mixed nanotubes. The degree of mixing for the control 
conjugates, as with previous hydrophilic CP-polymers without a stabilising 
hydrophobic core block, was around 90% or higher, indicating dynamic exchange of 
subunits to form statically mixed nanotubes.5 Also the diblock conjugate after 7 days 
reached a final degree of mixing of only 41%, which suggests that the nanotubes are 
not fully mixing and discrete sections in the supramolecular assembly remain 
unchanged. The significant retardation in the rate of exchange (K1 and K2), provides 
further evidence the hydrophobic pBA core-block stabilises the hydrogen bonded 
peptide self-assembly; affording a much less dynamic system. 
4.4 Composition of supramolecular diblock conjugates  
To directly visualise the assembled peptide aggregates and any exchange between 
aggregates we imaged the nanotubes using super-resolution fluorescence microscopy, 
specifically direct stochastic optical reconstruction microscopy (STORM)18. 
Representative STORM images are shown in Figure 4.7 and also in the experimental 
section 4.6.13. In general the aggregates were well suited to imaging using STORM 
and the resolution of the final images were approximately 10 – 20 nm as calculated 
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using the Fourier ring correlation method.19 The co-injected and premixed conjugates 
were prepared using the same method as the FRET ratio study (vide supra). The 
general size and shape of the aggregates seemed similar. In the premixed samples the 
Cy3 and Cy5 dyes were significantly co-localised, suggesting the aggregates were all 
formed from combinations of Cy3 and Cy5 labelled peptides. In contrast, the co-
injected Cy3 and Cy5 diblock conjugates, left to mix after 1 day, featured much more 
aggregates which were just a single colour, showing that the Cy3 and Cy5 dyes were 
not as well mixed as in the premixed sample.  
The stability of the hydrophobic core prevents the free exchange of CP-conjugates 
between nanotubes, explaining why the Cy3 and Cy5 cannot be seen randomly 
distributed throughout the nanotubes as is the case for the premixed sample. Moreover, 
in several cases block-like structures can be observed where two conjugates with 
different colours were attached to each other. These observations demonstrate that the 
ends of the nanotubes are still able to assemble, to form supramolecular block co-
polymers. As a result some degree of FRET exchange was observed, but the degree of 
mixing remains still below 50% even after 7 days. Meijer and co-workers recently 
showed a similar phenomenon in organic solvents.20  
Due to the wavelength of the SLS laser overlapping with the dye on the FRET 
conjugates, another method was required to observe the average size of the aggregates. 
Multiple particle tracking was performed to work out an average hydrodynamic 
volume of the different dye conjugates and their mixtures. Most importantly, the co-
injected and premixed mixtures showed similar hydrodynamic radii (approx. 50 nm), 
see Table 4.3. It is worth noting that this is not a nanotube length, as the model assumes 
a spherical structure. The results nevertheless show that there are no significant 
differences in the average size between the aggregates.  
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Figure 4.7 Composition of cyclic peptide-polymer nanotubes. Schematic and 
stochastic optical reconstruction microscopy (STORM) of a) co-injected and b) 
premixed cyclic peptide-polymer-dye conjugates.  
4.5 Conclusion 
A new generation of supramolecular cylindrical nanostructures which are stable, bio-
compatible and easily functionalised have been reported. Unlike previous hydrophilic 
cyclic peptide conjugates which show fast dynamics and a low aspect ratio, by 
introducing a secondary hydrophobic driving force to stabilise the peptide assembly 
we observe the formation of a stable supramolecular polymer with a length above 100 
nm. Furthermore, controlling the dynamic behaviour using additional hydrophobic 
interactions enables the formation of supramolecular block co-polymer structures. 
With these experiments we prove that these highly functional supramolecular polymer 
brushes are able to form defined nanostructures similar to previously reported CDSA 
materials but, importantly for biological applications, in aqueous conditions. 
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4.6 Experimental 
4.6.1 Materials 
Fmoc-protected amino acids and coupling agents were purchased from Iris Biotech 
GmbH. Cyanine3 NHS ester and Cyanine5 NHS ester were obtained from Lumiprobe 
GmbH, Germany. The RAFT agent, (propanoic acid)yl butyl trithiocarbonate 
(PABTC), was synthesised in our group using literature protocol.50 The initiator V-
601 was purchased from Fujifilm Wako Pure Chemical Corporation. N-N-
Dimethylacryliamide (DMA, Sigma-Aldrich, 99%) and butyl acrylate (BA) were 
filtered through a basic aluminium oxide (Fisher Scientific) column to remove the 
radical inhibitor before polymerisation reactions. 
All other chemicals stated were purchased from Sigma-Aldrich now Merck, 
(Gillingham, UK) unless otherwise stated. Solvents were purchased from several 
departmental suppliers—Honeywell, Fisher and Sigma-Aldrich.  
4.6.2 Methods 
 
4.6.2.1 Nuclear Magnetic Resonance (NMR) spectroscopy 
1H NMR spectra were measured using a Bruker DPX-300 or DPX-400 NMR 
spectrometer, which operated at 300.13 and 400.05 MHz, respectively. The residual 
solvent peaks were used as internal references. The following deuterated solvents were 
used: chloroform-d (CDCl3), dimethyl sulfoxide-d6, deuterium oxide (D2O). 
Chemical shift values (δ) are reported in ppm.  
4.6.2.2 Size Exclusion Chromatography (SEC) 
Molar mass distributions were obtained using size exclusion chromatography (SEC). 
The polymers and conjugates were measured using the Agilent 390-LC MDS 
instrument which measured differential refractive index (DRI). Samples were 
prepared around 1-3 mg mL-1 and filtered using 0.2 µM PTFE filters before auto-
sampler injections.  
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PC Agilent 1260 Infinity II-MDS Agilent 1260 Infinity II-MDS Agilent PL50 
Eluent THF with 2% TEA + 0.01 % 
BHT 
DMF with 5mM NH4BF4 DMF + 0.1 % LiBr 
Detectors RI, Viscometer, LS, MWD RI, Viscometer, VWD, LS DRi, UV 
Columns 2 x PLgel Mixed-C 2 x PLgel Mixed-D 2xPolargel M 
Columns 
Calibration 
range 
200 to 2,000,000 g/mol (PS 
equivalent) 
200 to 400,000 g/mol (PS 
equivalent) 
1,000 to 500,000 
g/mol 
 (http://www.chem.agilent.com/Library/brochures/5990-7994-GPCorganics-Apr11-
9lo.pdf) 
4.6.2.3 High-Performance Liquid Chromatography (HPLC) 
High-performance liquid chromatograms were measured using an Agilent 
Technologies 1200 Series, equipped with a Luna 5u C18 100 Å, 250 mm × 4.6 mm 
column. Acetonitrile/water was used. All solvents contained 0.04 vol% TFA. The 
following method was used: 0-5 mins 5:95 (Acetonitrile: Water), 5-35 mins gradient 
from 5:95 to 95:5 (Acetonitrile: Water), 35-38 mins gradient from 95:5 to 5:95 
(Acetonitrile: Water). 
4.6.2.4 Mass Spectrometry (MS) 
The peptides and conjugates before polymer attachment were analysed using 
electrospray ionisation (ESI) - Mass spectrometry (MS) on the either the Agilent 
6130B single Quad or Bruker MicroToF instruments. 
4.6.2.5 Ultraviolet–Visible (UV–Vis) Absorption Spectroscopy 
Spectroscopy: UV–vis absorption spectra were measured using an Agilent 
Technologies Cary 60 UV–vis spectrometer. The solutions were all made to the same 
concentration (35 µM). 
4.6.2.6 Fluorescence Emission Spectroscopy 
Fluorescence emission spectra were measured using an Agilent Technologies Cary 
Eclipse Fluorescence spectrometer. The FRET studies were performed using an 
absorption maxima of the donor conjugate (measured in using UV-Vis spectroscopy). 
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4.6.3 Synthesis and Characterisation 
4.6.3.1 Polymer synthesis 
4.6.3.1.1 pBA polymerisation 
 
Scheme 4.1 Preparation of diblock co-polymer of butyl acrylate (BA) and dimethyl 
acrylamide (DMA). 
pBA (19): For the synthesis of the first block, PABTC (0.214 g, 0.900 mmol, 1 eq.), 
butyl acrylate (1.153 g, 9.00 mmol, 10 eq.), V601 azo-initiator (4.14 mg, 0.018 mmol, 
0.02 eq.) and 1,4-dioxane (0.901 g) were all weighed into a vial with a magnetic stirrer 
and sealed with a rubber septum. The solution was mixed thoroughly and 
deoxygenated by bubbling nitrogen for ca. 10 min. The vial was then placed in an oil 
bath set at 70oC for 20 hours. Samples conversion, calculated from 1H NMR, during 
the polymerisation were taken using a degassed syringe. After the polymerisation, the 
mixture was cooled and opened to air. 1H NMR and GPC of these polymers were taken 
to determined, conversion and molecular weight.  
Yield was not calculated as the solution containing the macroCTA was used directly 
to synthesis the following diblock. 1H NMR (CDCl3, 300 MHz, δ ppm): 0.94 (3H, 
H3C-CH2-RAFT agent + 3H, H3C-CH2-BA monomer), 1.39 (2H, H3C-CH2-BA 
monomer), 1.61 (2H, H3C-CH2-CH2-BA monomer), 3.35 (-CH2-S- RAFT agent), 
4.05 (2H, -CH2-O-C(O)-BA monomer). Mn = 1,760 g mol
-1, Ð = 1.15 (THF SEC, 
Agilent EasyVial PMMA calibration). 1H NMR spectrum in Appendix Figure 4.19 
and SEC chromatogram in Figure 4.2. 
 
4.6.3.1.2 pDMA chain extension (pBA-b-pDMA) 
pBA-b-pDMA (20): An exact aliquot of the mixture containing the first block (pBA) 
was taken by calculating the moles of MacroCTA (pBA-block) from the known 
concentration of your pBA polymerisation. In a new vial, the aliquot containing your 
pBA-block (900 mg, 0.254 mmol, 1 eq.), N,N-Dimethylacrylamide (DMA) (1.134g, 
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11.43 mmol, 45 eq.), V-601 (0.84 mg, 0.0143 eq.) and 1,4-Dioxane (1.382 g) were 
added together. The solution was mixed thoroughly and deoxygenated by bubbling 
nitrogen for ca. 10 min. The vial was then placed in an oil bath set at 70oC for 20 
hours. The solution was precipitated in diethyl ether and dried in a vacuum oven. The 
product was a yellow solid.  
Yield = 85% (1.2292 g); 1H NMR (CDCl3, 300 MHz, ppm): 0.94 (3H, H3C-CH2-
RAFT agent + 3H, H3C-CH2-BA monomer), 1.37 (2H, H3C-CH2-BA monomer), 1.61 
(2H, H3C-CH2-CH2-BA monomer), 2.91 (6H, -N-(CH3)2), 3.34 (-CH2-S- RAFT 
agent), 4.03 (2H, -CH2-O-C(O)-BA monomer). Mn = 5,000 g mol
-1, Ð = 1.13 (THF 
SEC, Agilent EasyVial PMMA calibration). 1H NMR spectrum in Appendix Figure 
4.20 and SEC chromatogram in Figure 4.2. 
4.6.3.1.3 pDMA polymerisation 
 
Scheme 4.2 Preparation of homopolymer of dimethylacrylamide (DMA). 
pDMA (21): For the synthesis of the pDMA homopolymer, PABTC (50.06 mg, 0.210 
mmol, 1 eq.), DMA (1.041 g, 10.50 mmol, 50 eq.), VA-044 azo-initiator (1.49 mg, 
4.60 µmol, 0.0219 eq.) and a 1:4 co-solvent of 1,4-dioxane (0.421 mL)and deionised 
water (1.264 mL) respectively were all weighed into a vial with a magnetic stirrer and 
sealed with a rubber septum. The solution was mixed thoroughly and deoxygenated 
by bubbling nitrogen for ca. 10 min. The vial was then placed in an oil bath set at 70oC 
for 20 hours. Samples conversion, calculated from 1H NMR, during the polymerisation 
were taken using a degassed syringe. After the polymerisation, the mixture was cooled 
and opened to air. 1H NMR and GPC of these polymers were taken to determined, 
conversion and molecular weight. The solvent was evaporated using the aid of 
nitrogen flow, then the polymer was resuspended in dioxane and precipitated in hexane 
(repeat 3 times) and dried in a vacuum oven. The product was a yellow solid. 
Yield = 88% (1.0483 g); 1H NMR (CDCl3, 300 MHz, ppm): 0.89 (3H, H3C-CH2-
RAFT agent), 1.08 (3H, H3C-(C(O)-OH)-RAFT agent), 1.85-1.46 (4H, H3C-CH2-
CH2-RAFT agent + 2H, -CH-CH2- polymer backbone), 2.62 (-CH-CH2- polymer 
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backbone), 2.80-3.25 (6H, -N-(CH3)2) Mn = 5,000 g mol
-1, Ð = 1.13 (THF SEC, 
Agilent EasyVial PMMA and PS calibration). 1H NMR spectrum in Appendix Figure 
4.21 and SEC chromatogram in Figure 4.2. 
4.6.3.2 Conjugation of the polymer to cyclic peptide 
4.6.3.2.1 CP-(pBA-pDMA)2 – Diblock conjugate 
 
Scheme 4.3 Preparation of cyclic peptide-diblock conjugates 
CP-(pBA-pDMA)2 (22): The cyclic peptide (2), cyclo(D-Leu-Lys-D-Leu-Trp)2, was 
synthesised using literature protocol.21 CP (15 mg, 13.88 µmol, 2.2 eq.) was dissolved 
in DMF (0.5 mL) with the aid of sonication. In a separate vial, pBA-pDMA (20) (0.171 
g, 30.54 µmol, 2.2 eq.), HATU (0.0116 g, 30.54 µmol, 2.2 eq.) and DIPEA (0.0108 g, 
83.28 µmol, 6 eq.) were dissolved in 0.5mL DMF and shaken for 30 minutes then 
added to the CP solution. The combined solution was shaken for 2 days at room 
temperature. The product then precipitated in diethyl ether five times. To ensure the 
polymer stays in solution and is removed with the supernatant during the precipitation 
procedure a small amount of methanol used to redissolved both polymer and conjugate 
before precipitation solvent, diethyl ether, was reintroduced. A minimum amount of 
diethyl ether was used to precipitate the conjugate. The purification of the excess 
polymer can be monitored via SEC traces in Figure 4.3. Yield = 47% (84.5 mg). 
4.6.3.2.2 CP-(pDMA)2 – Control conjugate 
 
Scheme 4.4 Preparation of cyclic peptide-pDMA conjugates 
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CP-(pDMA)2 (23): CP (15 mg, 13.88 µmol, 2.2 eq.) was dissolved in DMF (0.5 mL) 
with the aid of sonication. In a separate vial, pDMA (21) (0.174 g, 30.54 µmol, 2.2 
eq.), HATU (0.0116 g, 30.54 µmol, 2.2 eq.) and DIPEA (0.0108 g, 83.28 µmol, 6 eq.) 
were dissolved in 0.5mL DMF and shaken for 30 minutes then added to the CP 
solution. The combined solution was shaken for 2 days at room temperature. The 
solvent was evaporated with the aid of a nitrogen flow. The product then purified using 
centrifuge dialysis tubes with a molecular weight cut-off of 10 kDa (Merck Millipore). 
The purification of the excess polymer can be monitored via SEC traces in Figure 
4.3.Yield = 41% (71.5 mg). 
4.6.3.3 Synthesis of cyclic peptide-dye conjugates 
4.6.3.3.1 Dye conjugation to the cyclic peptide 
 
Scheme 4.5. Preparation of Cyannine3 conjugated cyclic peptide-polymer 
conjugates 
Cy3-CP-protected (24): The partially deprotected cyclic peptide was synthesised 
according literature protocol.3 This cyclic peptide was dissolved in 0.5 mL of DMF 
with the aid of sonication. N,N-Diisopropylethylamine (DIPEA) (0.0117 g, 90.7 µmol, 
6 eq.) was added to the CP solution and mixed. Cyanine3 NHS ester (purchased from 
Lumiprobe GmbH) (0.011g, 17.4 µmol, 1.15 eq.) was added to the CP solution and 
stirred for 3 days. The reaction was followed via HPLC, in Appendix Figure 4.22. The 
purified peptides were characterized by mass spectrometry (electrospray ionization, 
ESI) (Table 4.1). Yield: 78% (20.6 mg). 
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4.6.3.4 Deprotection of the dye conjugated cyclic peptide 
 
 
Scheme 4.6 Deprotection of Boc groups on the cyclic peptide-dye conjugates 
Cy3-CP-deprotected (26): Boc groups were removed in using a deprotection solution 
of TFA/TIPS/H2O (18:1:1 vol, 5 mL). The dye conjugated Boc protected CP (24) 
(20.632 mg) was agitated for 3 hours in the deprotection solution, then triturated using 
ice-cold diethyl ether and washed twice more with ice-cold diethyl ether. The pink 
precipitate was collected and dried under vacuum. The reaction was followed via 
HPLC, Appendix Figure 4.22. Mass spectra attributions can be found in Table 4.1. 
Yield: 94% (25.7 mg).  
Cy5 conjugates  
 
Scheme 4.7 Preparation of Cy5 conjugated cyclic peptides. 
The Cyannine5 conjugates (25 and 27) (Scheme 4.7) were synthesised using the same 
procedure to synthesise Cyannine3 conjugates. The reaction was followed via HPLC, 
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Appendix Figure 4.23. Mass spectra attributions can be found in Table 4.1. Cy5-CP-
Protected (7): Yield: 92% (25.4 mg). Cy5-CP-Deprotected (27): Yield: 65% (13.7 
mg). 
 
4.6.3.5 Conjugation of the polymers to the cyclic peptide-dye conjugates 
4.6.3.5.1 Cy3-CP-(pBA-pDMA)2 – Diblock dye conjugate 
  
Scheme 4.8 Preparation of cyclic peptide-dye-diblock polymer conjugates 
Cy3-CP-(pBA-pDMA)2 (28): Cyclic peptide-dye conjugate (Cy3-CP-dep, 26) (16 mg, 
10.9 µmol, 1 eq.) was dissolved in DMF (0.5 mL) with the aid of sonication. In a 
separate vial, pBA-pDMA (22) (0.138 g, 24.1 µmol, 2.2 eq.), HATU (9.2 mg, 24.1 
µmol, 2.2 eq.) and DIPEA (8.5 mg, 65.7 µmol, 6 eq.) were dissolved in 0.5 mL DMF 
and shaken for 30 minutes then added to the CP solution. The combined solution was 
shaken for 3 days at room temperature. The product then precipitated in diethyl ether 
five times. To ensure the polymer stays in solution and is removed with the supernatant 
during the precipitation procedure a small amount of methanol used to redissolved 
both polymer and conjugate before precipitation solvent, diethyl ether, was 
reintroduced. A minimum amount of diethyl ether was used to precipitate the 
conjugate. The purification of the excess polymer can be monitored via SEC traces 
(see Appendix 4.24). Yield = 43% (58.3 mg).  
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4.6.3.5.2 Cy3-CP-(pDMA)2 – Control dye conjugate 
 
Scheme 4.9 Preparation of cyclic peptide-dye-homopolymer conjugates  
Cy3-CP-(pDMA)2 (30): Cyclic peptide-dye conjugate (Cy3-CP-dep, 26) (6.2 mg, 4.17 
µmol, 1 eq.) was dissolved in DMF (0.5 mL) with the aid of sonication. In a separate 
vial, pDMA (21) (51.2 mg, 9.16 µmol, 2.2 eq.), HATU (3.48 mg, 9.16 µmol, 2.2 eq.) 
and DIPEA (3.23 mg, 25.0 µmol, 6 eq.) were dissolved in 0.5mL DMF and shaken for 
30 minutes then added to the CP solution. The combined solution was shaken for 3 
days at room temperature. The solvent was evaporated with the aid of a nitrogen flow. 
The product then purified using centrifuge dialysis tubes with a molecular weight cut-
off of 10 kDa (Merck Millipore). The purification of the excess polymer can be 
monitored via SEC traces (see Appendix Figure 4.24). Yield = 7% (3.174 mg).  
The Cyannine5 conjugates (29 and 31) were synthesised using the same procedure to 
synthesise Cyannine3 conjugates. The purification of the excess polymer can be 
monitored via SEC traces (see Appendix 4.24). Cy5-CP-(pBA-pDMA)2 (29): Yield: 
49% (34.1 mg). Cy5-CP-(pDMA)2 (31): Yield: 8% (4.390 mg). 
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Table 4.1 Electrospray ionisation (ESI) - Mass spectrometry (MS) characterisation of 
cyclic peptide and dye conjugates carried out on the Agilent 6130B single Quad. 
  
Sample No. Compound a 
ESI (g mol-1)  
Calculated Found Attribution 
 Linear peptide (LP) - 
standard 
1499.7 1499.9 [M+H]+ 
 Cyclic peptide (CP) - 
standard 
1081.7 1081.7 [M+H]+ 
 CP-Dde protected 1509.9 1509.94 [M+Na]+ 
 CP-Dde deprotected 1323.9 1323.8 [M+H]+ 
24 Cy3-CP-Boc protected 892.6 892.9 [M+Na]2+ 
25 Cy5-CP-Boc protected 905.6 905.9 [M+Na]2+ 
26 Cy3-CP-Boc deprotected 731.5 731.8 [M+H] 2+ 
27 Cy5-CP-Boc deprotected 744.5 744.8 [M+H] 2+ 
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4.6.4 1,6-diphenylhexatriene (DPH) dye experiment 
1,6-diphenylhexatriene (DPH) was dissolved to make a 1 mg mL-1 solution in DMSO. 
Under the UV lamp (365 nm) the dye fluorescence was clearly observed. In separate 
vials, accurately prepared 1 mg mL-1 solutions of the diblock and control conjugates 
solutions were made up in de-ionized water. The solutions were left on a shaker 
overnight to full dissolve and equilibrate. Before dye addition the fluorescence of the 
de-ionised water and DMSO (solvent only) and the conjugates in solution were 
checked. Using a micro-pipette exactly 5% vol ratio of the dye solution in DMSO was 
added to the conjugates.  
The fluorescence of DPH quenches in the presence of water. As the DPH dye enters a 
hydrophobic region where it can shield itself from the water, fluorescence can once 
again be observed. When the dye enters the hydrophobic pBA core around the cyclic 
peptide, the dye fluorescence can be observed. Clear fluorescence emission in the 
diblock conjugate solution was observed after 10 mins. No fluorescence was observed 
in the solvent or the control conjugate solution after 3 days.  
 
Figure 4.8 Images of cyclic peptide polymer conjugates with the addition of DPH dye. 
Upon dye addition, fluorescence was observed in the case of the diblock conjugate 
solution. No visible fluorescence was observed for the control conjugate, absence of 
the hydrophobic core. 
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4.6.5 Static Light Scattering (SLS) 
 
The SLS data were obtained using the ALV/CGS-3 Compact Gonimeter System. A 
range of different concentrations of the diblock and control conjugates were measured 
using SLS, before and after sonication. The compounds were first accurately measured 
in a vial and corresponding volumes of water were added to yield various different 
concentrations (0.5–3 mg mL−1). Before measuring, the solutions were filtered using 
0.45 × 10−6 m membrane PTFE lined filters to remove any large aggregates. 
 
Figure 4.9 Evolution of KC/R of diblock conjugate (CP-(pBA-pDMA)2) in water as 
a function of q² obtained by static light scattering. a) Before sonication, b) 1 hour 
after sonication and c) 3 days after sonication. d) Evolution of 1/Ma of diblock 
conjugate in water as a function of concentration before sonication, 1 hour after and 
3 days after sonication obtained by static light scattering. 
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Figure 4.10 Evolution of KC/R of control conjugate (CP-(pDMA)2) in water as a 
function of q² obtained by static light scattering. a) Before sonication, b) 1 hour after 
sonication and c) 3 days after sonication. d) Evolution of 1/Ma of control conjugate 
in water as a function of concentration before sonication, 1 hour after and 3 days 
after sonication obtained by static light scattering. 
 
Table 4.2 Length of the nanotubes calculated from static light scattering over a range 
of concentrations (0.1 – 3.0 mg mL-1) before and after sonication. 
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4.6.6 Single-Angle Neutron Scattering (SANS) 
 
SANS was carried out on the LARMOR small-angle diffractometer at the ISIS Pulsed 
Neutron Source (STFC Rutherford Appleton Laboratory, Didcot, UK). Prior to 
measurement, each sample was dissolved in D2O and placed in a 2 mm quartz cuvette. 
The scattering cross-section was measured over a Q-range of 0.004 - 0.5 Å-1 where Q 
is defined as:  
𝑄 =
4πsin
θ
2
𝜆
  (1) 
Here, θ is the scattered angle, and λ is the incident neutron wavelength. A Q-range of 
0.004 - 0.5 Å-1 was achieved utilizing an incident wavelength range of 0.9 - 13.3 Å. 
The detector is located 4.1 m from the sample and is 664 mm wide * 664 mm high 
with the beam in the centre of the detector. The beam size is 6 mm wide and 8 mm 
high. Each raw scattering data set was corrected for the detector efficiencies, sample 
transmission and background scattering and converted to scattering cross-section data 
(∂Σ/∂Ω vs. Q) using the instrument-specific software. These data were placed on an 
absolute scale (cm-1) using the scattering from a standard sample (a solid blend of 
hydrogenous and perdeuterated polystyrene) in accordance with established 
procedures. 
Following data acquisition, the SASfit software programme was used to model the 
data.  In all cases several fixed parameters were used; concentration, the radius of the 
core, and SLD values (for the solvent, core peptide, and polymer shell). 
Values for SLD were calculated using the following equation; 
𝑆𝐿𝐷 =
𝜌𝑁𝑎 ∑ 𝑏𝑖
𝑁
𝑖=1
∑ 𝑀𝑖
𝑁
𝑖=1
  (2)
Where ρ is the bulk density of the material, Na is Avogadro’s constant, bi is the 
scattering length contributions from the N atoms within the unit cell, and M is the 
atomic mass of N atoms.  Values for individual atomic scattering lengths and atomic 
weights were taken from the NIST database.22, 23 SLD parameters were calculated for 
the solvent, polymer, and peptide and used as fixed values in the fitting analysis.  The 
use of data from previous SANS experiments provided the vale for cylinder radius of 
0.4 nm.    
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The hairy-cylinder model, is a combination model adapted from the form factor of a 
micelle, with a rod-like core as an additionally structure factor.  The form factor can 
be described as; 
𝑃(𝑞) =  𝑁2𝛽𝑠
2𝐹𝑠(𝑞) + 𝑁𝛽𝑐
2𝐹𝑐(𝑞) + 2𝑁
2𝛽𝑠𝛽𝑐𝑆𝑠𝑐(𝑞) + 𝑁(𝑁 − 1)𝛽𝑐
2𝑆𝑐𝑐(𝑞) 
Where N is the aggregation number, and 𝛽𝑠 = 𝑉𝑠 (𝜌𝑠 − 𝜌𝑠𝑜𝑙𝑣) / 𝛽𝑐 = 𝑉𝑐 (𝜌𝑐 − 𝜌𝑠𝑜𝑙𝑣) 
is the total excess scattering lengths of the cylindrical core and in the corona, 
respectively. Vs and Vc are the volumes of the core and in the corona, respectively.  𝜌s 
and 𝜌c are the corresponding scattering length densities and 𝜌solv is the scattering 
length density of the surrounding solvent, calculated as previously discussed. The 
solutions were prepared by dissolving the conjugates in 1 mg mL-1 of D2O. 
Fixed variables 
Vbrush - the molecular volume of the polymer arms - Calculated as the Mw of the 
polymer divided by Avogadro’s constant (Na) and multiplied by the density 
R_core = 5 Å fixed as the radius of the CP 
d – fixed at 1 – non penetration of chains into the cylindrical core of the CP 
eta_core, eta_brush, eta_solv – SLD value calculated using molecular structures  
Table 4.3 Parameters and results from fitting the SANS scattering data to a hairy-
cylinder model
Diblock conjugate – Contribution 1 – CYL+Chains (RW)  
Parameters Fit Value Units 
Delta  2.45747e-5  
R_core  5 Å 
n_agg  0.0601087  
V_brush  14776 cm3 
eta_core  8.20995e-007 Å-2 
eta_brush  1.64e-006 Å-2 
eta_solv  6.33e-006 Å-2 
xsolv_core  183.893  
Rg  13.9993 Å 
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h  1  
H  1000 Å 
Diblock conjugate - Contribution 2 – extended Guinier law  
Parameters Fit Value Units 
Delta  0.133184  
I0  0.133184  
a  0.88974  
Ra  41.9261  
chisqr: 256, red. chisqr: 6.57 
Control conjugate - CYL+Chains (RW) - chisqr: 26.8, red. chisqr: 1.03 
Parameters Fit Value Units 
Delta  0.083845  
R_core  5 Å 
n_agg  0.00453034  
V_brush  15757 cm3 
eta_core  8.20995e-007 Å-2 
eta_brush  9.57751e-007 Å-2 
eta_solv  6.33e-006 Å-2 
xsolv_core  0.572701  
Rg  12.0219 Å 
h  1  
H  492.444 Å 
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4.6.7 Transmission Electron Microscopy (TEM) 
 
Carbon coated grids, carbon film on copper 300 mesh, were purchased from EM 
Resolutions.  
Solutions of CP-diblock conjugate in water at 1 mg mL−1 were prepared by direct 
dissolution of the solid in filtered ultra-pure water. 10μL of solution was dropcast on 
freshly glow-discharged carbon-coated grids placed on filter paper. Bright field TEM 
micrographs were obtained with a Jeol 2100Plus is operating at 200 kV, equipped with 
a Gatan OneView IS camera. 
      
 
Figure 4.11 TEM images of diblock conjugated cyclic peptides (CP-(pBA-pDMA)2) 
prepared in water (1 mg/mL). 
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4.6.8 Toxicity 
4.6.8.1 Cell culture 
PC-3 (epithelial prostate cancer cells) cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) and 
2 mM of L-glutamine and penicillin at 37oC in a humid 5% CO2 environment. Cells 
were typically passaged at 80-90% confluence. 
4.6.8.2 Cytotoxicity assay (XTT/PMS) 
Toxicity of the conjugates was assessed using a standard XTT protocol. The CP 
conjugates to be tested were dissolved in water with 0.5% DMSO in order to obtain 
solutions at 500 μM. These solutions were used to prepare multiple dilutions in a 
mixture of supplemented culture media (DMEM) and PBS (50:50) at the following 
concentrations: 100, 50, 10, 1 and 0.1 μM. PC-3 cells were seeded in a transparent 
Greiner 96 well-plate at a density of 10,000 cells per well and incubated for 24 h. The 
culture media was then replaced by 100 μL of the prepared solutions. After 24 h 
incubation, the medium was removed, the cells were washed once with PBS buffer 
before adding fresh media supplemented with 25 μL of XTT solution (1 mg·mL-1) 
containing N-methyl dibenzopyrazine methyl sulfate (PMS) (25 μmol.L-1). Cells were 
incubated for another 24 h. Absorbance was then directly measured using a BioTek™ 
Cytation™ 3 Cell Imaging Multi-Mode Reader at 450 nm and 650 nm (background). 
Two repeats of this experiment were performed; the error bars plotted are standard 
error of the mean. 
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Figure 4.12 Toxicity profile for diblock (CP-(pBA-pDMA)2) and control (CP-
(pDMA)2) conjugates. 
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4.6.10 UV-vis spectroscopy 
 
 
 
Figure 4.13 UV absorption spectra of Cy3-CP-Diblock and Cy5-CP-Diblock 
conjugates in water at 35 µM. 
 
4.6.11 Fluorescence emission spectroscopy 
 
 
*N.B Cy5 conjugate notably less fluorescent (Detector voltage set to high 800 V) 
Figure 4.14 Fluorescence emission spectra of Cy3-CP-Diblock and Cy5-CP-Diblock 
conjugates in water at 35 µM. 
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4.6.12 FRET exchange study 
Solutions of Cy3 and Cy5 conjugates were prepared in water at 35 µM. The FRET 
ratio over time was measured, after co-injection of the dye conjugate pair (1:1 vol 
ratio), by fluorescence emission microscopy. Upon excitation at the donor absorption 
maxima, the emission at donor and acceptor maxima of the dyes were used to calculate 
the FRET ratio (see main manuscript for definition). The energy transfer from the 
donor to the acceptor i.e. the FRET measured, can be related to the exchange of cyclic 
peptides between nanotubes in solution. Furthermore the change in FRET over time 
can be modelled to a second order decay function,5, 24 to calculate the rate of exchange 
taking place. The fitting below was done using OriginPro software. Details of the fit 
can be found below. 
 
Figure 4.15 FRET exchange study of cyclic peptide dye conjugates with two 
polymer arms of a) diblock copolymer pBA10-b-pDMA40 or b) homopolymer 
pDMA50.
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4.6.13 Particle tracking and Stochastic Optical Reconstruction Microscopy 
(STORM) 
Particle tracking and Stochastic Optical Reconstruction Microscopy (STORM) 
experiments were performed with the sample at 1 mg/ml peptide concentration 
dissolved in de-ionised water (>18MΩ) and then filtered using a 0.45 μm cellulose 
acetate syringe filter (SupaTop). Images of the peptide aggregates were captured on 
our specially constructed STORM microscope and full details of the microscope is 
detailed in our previous work.18 For both experiments circular imaging spacers 
(Thermo Scientific) were fixed to cleaned glass microscope slides to create wells for 
the sample. Then, for the particle tracking experiments, 7.5 μL of the peptide solution 
was deposited in the well formed by the spacer and the slide and a circular glass 
coverslip was used to seal the sample into the well. The sample was illuminated and 
the diffusion of aggregates through the solvent was videoed at 100 fps for 30 secs. 
Care was taken to ensure only aggregates at least 10 μm from the surface were 
recorded to eliminate the risk of hydrodynamic drag from the surfaces. Background 
subtraction was performed in ImageJ on the raw videos using the “rolling-ball” 
algorithm.25 The position of particles in the processed videos were then tracked using 
our previously developed particle tracking software.26 
For the STORM experiments, 3 μL of sample was placed directly onto a cleaned glass 
coverslip to allow adsorption of the aggregates to the glass. Then, 4 μL of OxEA 
STORM imaging buffer27 was placed into the well on the microscope slide. The 
coverslip was then fixed over the well such that the imaging buffer and sample came 
into contact with each other and the total volume of liquid in the well was 7 μL. For 
the STORM images, at least 5,000 images of each aggregate were recorded at high 
laser intensity. To capture two colour images, two raw data sets were captured 
sequentially for each STORM image, one for the Cy5 dye (647 nm laser) and then 
another for the Cy3 dye (568 nm laser). Localisation of fluorophores in the raw data 
was then performed with the ImageJ plugin ThunderSTORM.28 The two resulting 
single colour images (one for Cy5 dye and one for Cy3 dye) were then combined into 
a two colour image. We calculated and corrected for any drift of the sample between 
recording the two single colour images by calculating the 2D cross-correlation of the 
Cy3 and Cy5 images. The peak of the 2D cross-correlation gave us an estimation of 
the drift and this was typically between 0 and 50 nm, we could then translate either 
Chapter 4 
 
133 
 
the Cy3 or Cy5 image and recombine them to form the final two colour image with 
correct alignment between the colour channels. 
To find the hydrodynamic radius of aggregates in the particle tracking experiments we 
calculated the ensemble averaged mean square displacement (MSD) of all the tracks 
output from our particle tracking software. In a purely viscous fluid, like the water 
used here, the MSD is linearly dependent upon time or lag time, 𝜏, and 
 〈𝑟〉 = 2𝑛𝐷𝜏𝛼, (2) 
  
where 𝑛 is the number of dimensions, 𝐷 is the diffusion co-efficient and α is the power 
law exponent (α=1 for purely viscous fluids).29 To verify our data, we performed a 
power law fit to Equation 1 and the results are shown in Figure S8. In all cases the 
MSD was found to be linearly dependent on lag time with power law exponents of 
1.0-1.1 in all cases, as expected. Using the gradient of each fit, the hydrodynamic 
radius, 𝑟ℎ, was found using the relation between it and the diffusion co-efficient, 
 
𝐷 =
𝑘𝑇
6𝜋𝜂𝑟ℎ
, 
(3) 
   
where η is the viscosity of water and kT is the thermal energy.29 Particle tracking 
experiments were performed individually on the Cy3 and Cy5 labelled peptides as 
well as mixtures of the Cy3 and Cy5 peptides when mixed before assembly (Premixed) 
or when assembled and then mixed in solution (after co-injection). All the results were 
similar with a hydrodynamic radius of approximately 50 nm, except for the aggregates 
formed by just Cy5 labelled peptides which were slightly smaller at 33 ± 1 nm, as 
shown in  
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Table 4.4 Tabular results of the particle tracking experiments. The fit was performed 
on the ensemble averaged MSD which was calculated from the average of many 
MSDs calculated from each individual track and the number in each sample is 
greater than 1,000 as shown. The power law fit exponent is shown and is close to 1 
as expected. A control experiment was also performed using fluorescent beads with a 
radius of 50 nm. Our results agreed with the manufactures specification of the size. 
Sample Number of 
tracks 
Power law fit 
exponent 
Hydrodynamic radius 
(nm) 
Cy3-CP-Diblock 1704 1.04 52 ± 2 
Cy5-CP-Diblock 1100 1.06 33 ± 1 
1 day after co-injection 1996 1.03 50 ± 2 
30 day after co-injection 2434 1.06 46 ± 2 
Premixed 3480 1.06 49 ± 2 
50 nm beads 18130 1.05 49 ± 2 
 
Figure 4.16 The MSD as a function of lag time for the experimental data (filled 
circles) and the fit to each data set (solid line). The Cy3-CP-Diblock, co-injected 
Cy3-CP-Diblock and Cy5-CP-Diblock conjugate and premixed samples all have 
similar hydrodynamic radii of about 50 nm and the Cy5 aggregates are slightly 
smaller with a hydrodynamic radius of 33 ± 1 nm. All MSDs were linearly 
dependent on lag time showing that the particles exhibited the expected Brownian 
motion and that the data was of high quality. Each MSD shown is the ensemble 
average from at least 1,000 individual particle MSDs. 
  
0.01 0.1 1
10-14
10-13
10-12
10-11
M
S
D
/ 
m
2
Lag time/ s
 Cy3-CP-Diblock
 fit
 Cy5-CP-Diblock
 fit
 Cy3-CP-Diblock and Cy5-CP-Diblock - 1 day postmixing 
 fit
 Cy3-CP-Diblock and Cy5-CP-Diblock - 30 day postmixing
 fit
 Cy3-CP-Diblock and Cy5-CP-Diblock - premixed
 fit
Chapter 4 
 
135 
 
4.6.14 Stochastic Optical Reconstruction Microscopy (STORM) Imaging 
 
 
Figure 4.17 A STORM image of the premixed sample, the scale bar is 10 μm (left). 
This image further shows that almost all aggregates feature some degree of co-
localisation and are therefore formed of a mixture of Cy3 and Cy5 labelled peptides. 
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Figure 4.18 A STORM image of the sample 1 day after co-injection of Cy3 and Cy5 
diblock conjugate, the scale bar is 5 μm long. After one day many of the aggregates 
are co-localised in the co-injected sample, however not to the same degree as in 
Figure 4.17. However, you can see how some of the aggregates have attached to 
each other at the ends, or potentially formed new multi-coloured aggregates since 
mixing. 
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4.7 Appendix 
 
 
Figure 4.19 1H NMR of pBA (19) polymer 
 
Figure 4.20 1H NMR of pBA-pDMA (20) polymer 
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Figure 4.211H NMR of pDMA (21) 
 
Scheme 4.10 Preparation of the linear and cyclic peptide. See literature procedure 
for details.21 
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Scheme 4.11 Preparation of the linear and cyclic peptide with orthogonal amine 
protection chemistry. See literature procedure for details.3 
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Figure 4.22 High Performance Liquid Chromatography (HPLC) spectra of the CP-
Cy3-Protected (24) and CP-Cy3-Deprotected (26). Detector set to 280 nm 
(tryptophan of cyclic peptide) and 563 nm (Cyanine 3 emission). 
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Figure 4.23 High Performance Liquid Chromatography (HPLC) spectra of the Cy5-
CP-Boc Protected (25) and CP-Cy5-Boc Deprotected (27). Detector set to 280 nm 
(tryptophan of cyclic peptide) and 662 nm (Cyanine 5 emission). 
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N.B. Due to the amounts and low yields obtained for these compounds, very dilute 
samples were measured and therefore a high signal to noise was observed. 
Figure 4.24 Size exclusion chromatography of the free polymer and the cyclic 
peptide-polymer dye conjugates in DMF + 0.1% LiBr. a) Cy3-CP-(pBA-pDMA)2 
(28), b) Cy5-CP-(pBA-pDMA)2 (29), c) Cy3-CP-(pDMA)2 (30) and d) Cy5-CP-
(pDMA)2 (31). 
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Chapter 5 Conclusion and Outlook 
 
Since the conception of self-assembling cyclic peptide nanotubes, many have 
envisioned their promising use in bio-therapeutics. The advent of water-soluble cyclic 
peptide systems, made possible by the attachment of hydrophilic polymers, has 
enabled our group to work on realising their potential as drug delivery vectors. 
However, to explain the biological results and improve the design of these systems in 
the future, a better understanding of the self-assembly was needed. The foremost 
question was whether the cyclic peptide nanotubes were dynamic or non-dynamic 
assemblies.  
In chapter 2, self-assembling cyclic peptides with FRET dyes were developed to study 
their dynamic behaviour. Using FRET dyes on the periphery, which are proximity-
dependent, the mixing of dye conjugates could be used to directly inform us of the 
exchanging CPs between the supramolecular assemblies. As both the dye and polymer 
are essential to the monitoring and composition, a ‘bottom up’ approach was used to 
synthesise an asymmetric self-assembling peptide, with two different conjugation 
sites. The orthogonality of the azide and amine on the cyclic peptide enabled us to 
selectively attach both a dye and polymer to the periphery.  
In the next chapter, the FRET pair conjugated on the cyclic peptide was used to 
directly monitor the dynamic behaviour of these supramolecular polymers in a range 
of different environments. The change in fluorescence emission was used to not only 
prove that the self-assemblies were rapidly disassembling and reassembling but also 
infer their rate of exchange and extent of mixing. Previously the hydrogen bond 
competitivity of the solvent was shown to directly affect the number of aggregation, 
here we showed this was also extremely important in governing the rate of exchange 
between nanotubes. Although in all cases near quantitative mixing is observed in 
comparison to premixed samples; the kinetics are much faster in aqueous solutions as 
compared to toluene - with the nanotubes almost fully mixed after 3 hours in water. 
Further studies showed that upon dilution the fluorescence associated with the FRET 
decreased which is related to steady decrease in the size of aggregates, a trend 
confirmed via static light scattering. In complex environments such as living cells, the 
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combination of FRET and confocal microscopy showed that the different nanotubes 
were independently transported into the same cell compartments. This ability to 
recombine even under such conditions as present in living cells makes these materials 
attractive as a basis system for tracking of transport pathways, especially as further 
ligands can easily be attached to the polymer chain. These results gave us the first 
insights into the dynamic nature of these promising supramolecular systems.  
For the final chapter, we reported a new generation of supramolecular cylindrical 
nanostructures which are stable, bio-compatible and easily functionalised. Unlike 
previous hydrophilic cyclic peptide conjugates which show fast dynamics and a low 
aspect ratio, by introducing a secondary hydrophobic driving force to stabilise the 
peptide assembly, we observed the formation of a stable supramolecular polymers 
with lengths above 100 nm. Furthermore, controlling the dynamic behaviour using 
additional hydrophobic interactions enables the formation of supramolecular block co-
polymer structures. With these experiments we prove that these highly functional 
supramolecular polymer brushes are able to form defined nanostructures, importantly 
for biological applications, in aqueous conditions. 
Building upon these systems, there are a number of avenues of interest to further this 
work in the future. First, would be to use the stabilising block in the design of future 
drug delivery vectors to prevent unwanted disassembly. Furthermore, installing a 
responsive polymer which could switch between hydrophobic and hydrophilic would 
enable us to control the stability of the supramolecular assembly. 
The second would be to realise controlled nanotubular length for these self-assembling 
nanotubes. The hydrophobic inter-shell, inspired by the semi-crystalline core-forming 
blocks from CDSA, could be used to grow uniform nanotubes if the assemblies are 
kinetically trapped. Few attempts have been made but a systematic study of growth 
would be the next step to control the supramolecular assembly process.  
To conclude, hopefully this thesis highlights the importance of understanding the 
supramolecular behaviour and how, using this information, we can better design future 
synthetic supramolecular polymers. The hope is that one day will be able to synthesis 
self-assemblies as complex as proteins to address a host of biological issues. For this, 
vast improvements in complexity and control will need to be achieved.   
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